| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 9.55e-10 | 14 | 169 | 6 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.81e-08 | 11 | 169 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 6.29e-07 | 37 | 169 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 7.42e-07 | 38 | 169 | 6 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 7.42e-07 | 38 | 169 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.46e-07 | 21 | 169 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 2.37e-06 | 4 | 169 | 3 | GO:0001010 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.43e-05 | 37 | 169 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.24e-05 | 46 | 169 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ROCK2 KIF18A MYH9 MID2 CENPE CENPF DCTN2 IFT74 SYNE1 TMOD2 NEB S100A4 SPTBN5 CCDC66 SYNE2 KIRREL1 MYH15 RP1 CEP57 CDH1 TBCE NIN | 1.53e-04 | 1099 | 169 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA3 MID2 TRIM21 NR3C1 TRIP11 ATXN7L3 CCAR1 MED23 MED27 PBXIP1 | 2.67e-04 | 303 | 169 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 3.18e-04 | 152 | 169 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA3 TRAF2 MYH9 NANOGP8 MID2 MED29 SYNE1 NANOG TRIM21 ICE1 NR3C1 TRIP11 CEP63 ATXN7L3 NANOGP1 AKAP9 SYNE2 CCAR1 GIGYF2 PLCB3 MED23 MED27 CDH1 PBXIP1 | 4.70e-04 | 1356 | 169 | 24 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.57e-04 | 79 | 169 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 7.00e-04 | 5 | 169 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF18A MYH9 ATRX CENPE ABCA13 SMC4 ATAD3A MYH15 DDX53 DDX43 POLQ DNAH5 ATP2A3 HSPA4 | 7.52e-04 | 614 | 169 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | endonuclease activity | 1.07e-03 | 136 | 169 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.69e-03 | 321 | 169 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | transcription factor binding | FOXO3 NCOA3 NANOGP8 MED29 CENPF NANOG WWP2 NR3C1 JUN EAF1 NANOGP1 HSPA4 PBXIP1 LRIF1 CREB3 | 1.89e-03 | 753 | 169 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.89e-03 | 206 | 169 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 2.04e-03 | 30 | 169 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.25e-03 | 31 | 169 | 3 | GO:0140033 | |
| GeneOntologyBiologicalProcess | DNA integration | 4.21e-10 | 13 | 167 | 6 | GO:0015074 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ROCK2 KIF18A MYH9 CEP85 CDC42BPA ATRX CENPE DCTN2 PPP1R12A CNTRL CEP192 CEP63 CCDC13 TEKT2 CCDC66 AKAP9 GCC2 SYNE2 RP1 CCDC102B PIBF1 TUBD1 DNAH5 TBCE NIN | 8.31e-10 | 720 | 167 | 25 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | ROCK2 KIF18A MYH9 CEP85 CDC42BPA ATRX CENPE DCTN2 IFT74 PPP1R12A CNTRL CEP192 ADCY3 CEP63 CCDC13 AKAP4 TEKT2 CCDC66 AKAP9 GCC2 SYNE2 KXD1 VPS13A RP1 CCDC102B PIBF1 TUBD1 DNAH5 TBCE NIN | 1.75e-09 | 1058 | 167 | 30 | GO:0007017 |
| GeneOntologyBiologicalProcess | protein localization to centrosome | 2.05e-08 | 38 | 167 | 7 | GO:0071539 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule cytoskeleton | 2.44e-08 | 59 | 167 | 8 | GO:0072698 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 2.49e-08 | 39 | 167 | 7 | GO:1905508 | |
| GeneOntologyBiologicalProcess | protein localization to cytoskeleton | 4.14e-08 | 63 | 167 | 8 | GO:0044380 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 2.07e-06 | 4 | 167 | 3 | GO:0042664 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.38e-06 | 48 | 167 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 5.15e-06 | 5 | 167 | 3 | GO:0042663 | |
| GeneOntologyBiologicalProcess | organelle assembly | CEP85 UBQLN1 CENPE CENPF IFT74 SYNE1 LRSAM1 CNTRL MTERF3 TMOD2 CEP192 RILPL1 NEB CEP63 CCDC13 AKAP4 TEKT2 CCDC66 SYNE2 CEP83 RP1 PIBF1 SCLT1 CTSD DNAH5 | 5.16e-06 | 1138 | 167 | 25 | GO:0070925 |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 5.28e-06 | 15 | 167 | 4 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 5.28e-06 | 15 | 167 | 4 | GO:0043696 | |
| GeneOntologyBiologicalProcess | centrosome localization | 8.74e-06 | 35 | 167 | 5 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 1.01e-05 | 36 | 167 | 5 | GO:0061842 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 1.02e-05 | 6 | 167 | 3 | GO:1903225 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 1.16e-05 | 18 | 167 | 4 | GO:2000035 | |
| GeneOntologyBiologicalProcess | cilium assembly | IFT74 SYNE1 CNTRL RILPL1 CCDC13 AKAP4 TEKT2 CCDC66 SYNE2 CEP83 RP1 PIBF1 SCLT1 DNAH5 | 1.61e-05 | 444 | 167 | 14 | GO:0060271 |
| GeneOntologyBiologicalProcess | protein localization to organelle | TNPO1 CCDC14 ROCK2 ANGPT1 RNF31 ATRX MID2 DCTN2 SYNE1 LRSAM1 CEP192 CEP63 CCDC66 RABEP1 GCC2 CD36 CEP83 VPS13A PIBF1 CDH1 HSPA4 HEATR3 GOLGB1 | 2.46e-05 | 1091 | 167 | 23 | GO:0033365 |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 2.83e-05 | 8 | 167 | 3 | GO:0009996 | |
| GeneOntologyBiologicalProcess | cilium organization | IFT74 SYNE1 CNTRL RILPL1 CCDC13 AKAP4 TEKT2 CCDC66 SYNE2 CEP83 RP1 PIBF1 SCLT1 DNAH5 | 3.46e-05 | 476 | 167 | 14 | GO:0044782 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | KIF18A MYH9 CDC42BPA CENPE CENPF DCTN2 CCDC186 SYNE1 TSC1 TRIP11 CEP63 SYNE2 KXD1 CEP83 PIBF1 | 3.95e-05 | 546 | 167 | 15 | GO:0051656 |
| GeneOntologyBiologicalProcess | stem cell division | 4.68e-05 | 49 | 167 | 5 | GO:0017145 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 5.81e-05 | 83 | 167 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 6.00e-05 | 10 | 167 | 3 | GO:1903224 | |
| GeneOntologyBiologicalProcess | centrosome-templated microtubule nucleation | 6.52e-05 | 2 | 167 | 2 | GO:0090222 | |
| GeneOntologyBiologicalProcess | Golgi organization | 6.93e-05 | 168 | 167 | 8 | GO:0007030 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 8.20e-05 | 11 | 167 | 3 | GO:0001714 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 1.08e-04 | 179 | 167 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | regulation of G protein-coupled receptor signaling pathway | 1.16e-04 | 181 | 167 | 8 | GO:0008277 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 1.41e-04 | 33 | 167 | 4 | GO:2000737 | |
| GeneOntologyBiologicalProcess | latent virus replication | 1.94e-04 | 3 | 167 | 2 | GO:0019045 | |
| GeneOntologyBiologicalProcess | release from viral latency | 1.94e-04 | 3 | 167 | 2 | GO:0019046 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular associated smooth muscle contraction | 1.94e-04 | 3 | 167 | 2 | GO:1904694 | |
| GeneOntologyBiologicalProcess | organelle localization | KIF18A MYH9 CDC42BPA CENPE CENPF DCTN2 CCDC186 SYNE1 TSC1 TRIP11 CEP63 AKAP9 SYNE2 KXD1 CEP83 PIBF1 | 1.96e-04 | 703 | 167 | 16 | GO:0051640 |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 2.47e-04 | 38 | 167 | 4 | GO:0035987 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 3.26e-04 | 17 | 167 | 3 | GO:0010454 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 3.86e-04 | 164 | 167 | 7 | GO:0007098 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 3.89e-04 | 18 | 167 | 3 | GO:0001711 | |
| GeneOntologyBiologicalProcess | chromosome segregation | KIF18A CEP85 CENPE CENPF DCTN2 SMC4 CEP192 NR3C1 CEP63 PPP1R7 SGO2 PIBF1 | 4.20e-04 | 465 | 167 | 12 | GO:0007059 |
| GeneOntologyBiologicalProcess | intracellular transport | TNPO1 ERVK-6 ANGPT1 CDC42BPA WASHC4 VPS39 IFT74 CCDC186 SYNE1 PPP1R12A TSC1 ICE1 RILPL1 SEC31B TRIP11 SPTBN5 GCC2 CD36 SYNE2 KXD1 VPS13A CDH1 ATP2A3 HSPA4 HEATR3 | 4.29e-04 | 1496 | 167 | 25 | GO:0046907 |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 4.80e-04 | 122 | 167 | 6 | GO:0051303 | |
| GeneOntologyBiologicalProcess | spindle organization | 4.93e-04 | 224 | 167 | 8 | GO:0007051 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy | 5.32e-04 | 173 | 167 | 7 | GO:0010508 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 5.85e-04 | 350 | 167 | 10 | GO:0051321 | |
| GeneOntologyBiologicalProcess | kinetochore organization | 6.23e-04 | 21 | 167 | 3 | GO:0051383 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 6.30e-04 | 178 | 167 | 7 | GO:0006261 | |
| GeneOntologyBiologicalProcess | microtubule nucleation by microtubule organizing center | 6.41e-04 | 5 | 167 | 2 | GO:0051418 | |
| GeneOntologyBiologicalProcess | endoderm formation | 6.61e-04 | 49 | 167 | 4 | GO:0001706 | |
| GeneOntologyBiologicalProcess | chromosome localization | 6.71e-04 | 130 | 167 | 6 | GO:0050000 | |
| GeneOntologyBiologicalProcess | endoderm development | 7.47e-04 | 88 | 167 | 5 | GO:0007492 | |
| GeneOntologyBiologicalProcess | mesodermal cell fate commitment | 8.20e-04 | 23 | 167 | 3 | GO:0001710 | |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC14 ROCK2 KIF18A CEP85 CENPF DCTN2 IFT74 PPP1R12A CNTRL UBR4 ANKRD62 CEP192 RILPL1 NR3C1 CEP63 CCDC13 RIC8B TEKT2 CCDC66 AKAP9 CEP83 CCDC15 CCDC102B PIBF1 SCLT1 TUBD1 CEP57 LRIF1 NIN | 2.50e-10 | 919 | 168 | 29 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | CCDC14 ROCK2 KIF18A CEP85 CENPF DCTN2 IFT74 PPP1R12A CNTRL UBR4 ANKRD62 CEP192 RILPL1 NR3C1 CEP63 CCDC13 RIC8B CCDC66 AKAP9 CEP83 CCDC15 PIBF1 SCLT1 CEP57 LRIF1 NIN | 5.73e-10 | 770 | 168 | 26 | GO:0005813 |
| GeneOntologyCellularComponent | ciliary transition fiber | 8.14e-07 | 10 | 168 | 4 | GO:0097539 | |
| GeneOntologyCellularComponent | centriolar satellite | 9.29e-06 | 128 | 168 | 8 | GO:0034451 | |
| GeneOntologyCellularComponent | centriole | 1.08e-05 | 172 | 168 | 9 | GO:0005814 | |
| GeneOntologyCellularComponent | condensed chromosome | KIF18A NANOGP8 ATRX CENPE CENPF DCTN2 NANOG PPP1R12A SMC4 NANOGP1 SGO2 | 4.01e-05 | 307 | 168 | 11 | GO:0000793 |
| GeneOntologyCellularComponent | pericentriolar material | 7.09e-05 | 28 | 168 | 4 | GO:0000242 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF18A MYH9 MID2 CENPE DCTN2 SYNE1 PPP1R12A TMOD2 TSC1 NEB RYR1 AKAP4 TEKT2 CCDC66 SYNE2 MYH15 RP1 TUBD1 CEP57 DNAH5 PBXIP1 TBCE NIN | 7.28e-05 | 1179 | 168 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF18A MYH9 MID2 CENPE DCTN2 SYNE1 PPP1R12A TMOD2 TSC1 NEB RYR1 AKAP4 TEKT2 CCDC66 SYNE2 MYH15 RP1 TUBD1 CEP57 DNAH5 PBXIP1 TBCE NIN | 8.06e-05 | 1187 | 168 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | cilium | TNPO1 PDE4C CENPF IFT74 CNTRL RILPL1 ADCY3 SPTBN5 AKAP4 TEKT2 CCDC66 AKAP9 CEP83 VPS13A RP1 SCLT1 TUBD1 DNAH5 NIN | 1.15e-04 | 898 | 168 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | microtubule | KIF18A MID2 CENPE DCTN2 TEKT2 CCDC66 RP1 TUBD1 CEP57 DNAH5 PBXIP1 TBCE NIN | 3.87e-04 | 533 | 168 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | cis-Golgi network | 6.17e-04 | 85 | 168 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | TRAF2 UBQLN1 WASHC4 RNF31 CENPF WWP2 CNTRL TSC1 TRIM21 ATXN7L3 AKAP4 KXD1 CEP83 MED23 ZSWIM4 MED27 SCLT1 NIN | 8.52e-04 | 972 | 168 | 18 | GO:0140535 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | GOLGA8S CCDC186 GOLGA8DP SGMS1 AKAP9 GCC2 MME CDH1 GOLGA1 GOLGA4 GOLGB1 | 9.41e-04 | 443 | 168 | 11 | GO:0098791 |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 9.71e-04 | 193 | 168 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | core mediator complex | 1.16e-03 | 26 | 168 | 3 | GO:0070847 | |
| GeneOntologyCellularComponent | myofibril | 1.68e-03 | 273 | 168 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.80e-03 | 276 | 168 | 8 | GO:0000775 | |
| MousePheno | absent extraembryonic ectoderm | 7.95e-06 | 15 | 126 | 4 | MP:0002583 | |
| Domain | GRIP_dom | 2.09e-06 | 12 | 154 | 4 | IPR000237 | |
| Domain | GRIP | 2.09e-06 | 12 | 154 | 4 | PS50913 | |
| Domain | - | 6.32e-05 | 10 | 154 | 3 | 1.10.220.60 | |
| Domain | Grip | 8.64e-05 | 11 | 154 | 3 | SM00755 | |
| Domain | GRIP | 8.64e-05 | 11 | 154 | 3 | PF01465 | |
| Domain | KASH | 4.01e-04 | 4 | 154 | 2 | IPR012315 | |
| Domain | KASH | 4.01e-04 | 4 | 154 | 2 | PS51049 | |
| Domain | KASH | 4.01e-04 | 4 | 154 | 2 | SM01249 | |
| Domain | KASH | 4.01e-04 | 4 | 154 | 2 | PF10541 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | TNPO1 DCTN2 IFT74 CNTRL CEP192 TRIP11 CEP63 AKAP9 CEP83 SCLT1 CEP57 | 1.98e-06 | 201 | 127 | 11 | M27472 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | KIF18A CENPE CENPF DCTN2 CNTRL SMC4 CEP192 CEP63 AKAP9 SGO2 CEP57 | 2.29e-06 | 204 | 127 | 11 | M4217 |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 2.57e-06 | 97 | 127 | 8 | M27478 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 1.31e-05 | 87 | 127 | 7 | M27194 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.43e-05 | 202 | 127 | 10 | MM15362 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 2.50e-05 | 96 | 127 | 7 | MM15207 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | TNPO1 DCTN2 IFT74 CEP192 TRIP11 CEP63 AKAP9 CEP83 SCLT1 CEP57 | 2.65e-05 | 217 | 127 | 10 | MM14708 |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 4.56e-05 | 72 | 127 | 6 | M27749 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | KIF18A MYH9 UBQLN1 CENPE DCTN2 TSC1 FCHO2 SEC31B TRIP11 F8 SPTBN5 RABEP1 GCC2 ACBD3 GOLGA1 GOLGA4 GOLGB1 | 4.95e-05 | 630 | 127 | 17 | M11480 |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | TNPO1 DCTN2 IFT74 CNTRL CEP192 TRIP11 CEP63 AKAP9 CEP83 SCLT1 CEP57 | 7.68e-05 | 297 | 127 | 11 | M27050 |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | KIF18A MYH9 UBQLN1 CENPE DCTN2 TSC1 FCHO2 SEC31B TRIP11 F8 SPTBN5 RABEP1 GCC2 CD36 ACBD3 GOLGA1 GOLGA4 GOLGB1 | 8.56e-05 | 725 | 127 | 18 | M27507 |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 8.87e-05 | 81 | 127 | 6 | M748 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 1.16e-04 | 85 | 127 | 6 | MM14906 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 1.48e-04 | 12 | 127 | 3 | M27569 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 1.48e-04 | 12 | 127 | 3 | MM15282 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.59e-04 | 90 | 127 | 6 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.69e-04 | 91 | 127 | 6 | M39426 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.14e-04 | 95 | 127 | 6 | M6729 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | KIF18A UBQLN1 CENPE DCTN2 TSC1 FCHO2 SEC31B TRIP11 F8 SPTBN5 GCC2 CD36 ACBD3 GOLGA1 GOLGA4 GOLGB1 | 2.21e-04 | 645 | 127 | 16 | MM15232 |
| Pathway | WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR | 3.33e-04 | 103 | 127 | 6 | M39826 | |
| Pathway | REACTOME_M_PHASE | TNPO1 KIF18A CENPE CENPF DCTN2 CNTRL SMC4 CEP192 CEP63 AKAP9 SGO2 CEP57 | 3.83e-04 | 417 | 127 | 12 | M27662 |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 4.44e-04 | 71 | 127 | 5 | MM15495 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 4.53e-04 | 200 | 127 | 8 | M864 | |
| Pathway | REACTOME_CELL_CYCLE | TNPO1 KIF18A ATRX CENPE CENPF DCTN2 SYNE1 PPP1R12A CNTRL SMC4 CEP192 CEP63 AKAP9 SYNE2 SGO2 CEP57 | 4.98e-04 | 694 | 127 | 16 | M543 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 6.23e-04 | 19 | 127 | 3 | M27493 | |
| Pubmed | ROCK2 NCOA3 MYH9 PDE4A CENPE CENPF SYNE1 PPP1R12A UBR4 TSC1 TRIM21 GIT2 TRIP11 PPP1R7 CCDC13 AKAP9 GPR158 FAM120C RABEP1 SYNE2 NUFIP2 CCAR1 GIGYF2 GOLGA1 GOLGA4 GOLGB1 | 2.89e-12 | 963 | 174 | 26 | 28671696 | |
| Pubmed | CCDC14 CEP85 DCTN2 CNTRL CEP192 CEP63 AKAP9 CCDC15 PIBF1 SCLT1 CEP57 NIN | 1.15e-11 | 146 | 174 | 12 | 21399614 | |
| Pubmed | ROCK2 MYH9 ATRX CENPF SYNE1 PPP1R12A CNTRL UBR4 UTP14A SMC4 TSC1 CAGE1 RRBP1 NEB PCF11 CCDC27 ATAD3A SYNE2 CEP83 VPS13A CCAR1 MYH15 POLQ TUBD1 CEP57 CDH1 ATP2A3 GOLGB1 ZNF292 | 1.69e-10 | 1442 | 174 | 29 | 35575683 | |
| Pubmed | Zfp281 functions as a transcriptional repressor for pluripotency of mouse embryonic stem cells. | 6.05e-10 | 4 | 174 | 4 | 21915945 | |
| Pubmed | 6.05e-10 | 4 | 174 | 4 | 22988117 | ||
| Pubmed | TNPO1 CDC42BPA ATRX DCTN2 SYNE1 WWP2 UBR4 MTERF3 UTP14A LAMB1 FASTKD5 CEP192 NR3C1 RRBP1 PCF11 AKAP9 ATAD3A SYNE2 VPS13A ROBO1 KIRREL1 PIBF1 ACBD3 HSPA4 PBXIP1 GOLGA4 GOLGB1 NIN | 1.57e-09 | 1487 | 174 | 28 | 33957083 | |
| Pubmed | ANGPT1 VPS39 SYNE1 KIAA0232 GIT2 RRBP1 ZNF518A GPR158 RHOBTB2 SYNE2 GIGYF2 NIN | 1.74e-09 | 225 | 174 | 12 | 12168954 | |
| Pubmed | TRAF2 MID2 VPS39 DCTN2 CCDC186 CNTRL RABEP1 GIGYF2 PIBF1 ATP2A3 HSPA4 GOLGB1 NIN | 2.40e-09 | 285 | 174 | 13 | 32838362 | |
| Pubmed | CCDC14 MYH9 CDC42BPA DCTN2 CCDC186 SYNE1 KIAA0232 CNTRL LAMB1 TRIM21 NEB JUN GIGYF2 ROBO1 PIBF1 GOLGB1 | 3.63e-09 | 486 | 174 | 16 | 20936779 | |
| Pubmed | 9.01e-09 | 6 | 174 | 4 | 22992952 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TNPO1 ROCK2 FOXO3 NCOA3 KIF18A ATRX DCTN2 IFT74 PPP1R12A RALGPS2 SMC4 GIT2 TRIP11 PPP1R7 JUN PIGT TEKT2 EAF1 POMP RABEP1 GCC2 NUFIP2 GIGYF2 PIBF1 TBCE | 1.19e-08 | 1321 | 174 | 25 | 27173435 |
| Pubmed | 2.09e-08 | 7 | 174 | 4 | 23444350 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 RAD52 CDC42BPA ATRX MID2 KIAA0232 PPP1R12A WWP2 CEP192 RILPL1 RRBP1 ADCY3 RIC8B SGMS1 MBNL2 GPR158 ATAD3A FAM120C RABEP1 GCC2 CCAR1 MME ZSWIM4 MED27 GOLGA4 GOLGB1 | 2.97e-08 | 1489 | 174 | 26 | 28611215 |
| Pubmed | CCDC14 KIF18A MED29 DCTN2 IFT74 PPP1R12A PARP2 GIT2 CCDC66 NUFIP2 CCAR1 SGO2 MED23 PIBF1 MED27 LRIF1 NIN | 3.07e-08 | 645 | 174 | 17 | 25281560 | |
| Pubmed | TRAF2 CEP85 UBQLN1 WASHC4 ATRX VPS39 IFT74 SYNE1 LRSAM1 UBR4 LAMB1 RILPL1 RRBP1 SEC31B TRIP11 CEP63 CCDC13 RABEP1 CCAR1 CCDC15 ROBO1 ACBD3 PBXIP1 ZNF292 | 3.07e-08 | 1285 | 174 | 24 | 35914814 | |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | WASHC4 CENPF VPS39 HS6ST2 CNTRL FASTKD5 AKAP9 GCC2 GIGYF2 HEATR3 GOLGB1 NIN | 3.99e-08 | 298 | 174 | 12 | 32353859 |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 4.54e-08 | 101 | 174 | 8 | 24613305 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 CEP85 ATRX CENPE IFT74 LRSAM1 TSC1 CEP192 GIT2 NR3C1 TRIP11 RABEP1 MED27 LRIF1 GOLGB1 NIN | 5.15e-08 | 588 | 174 | 16 | 38580884 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYH9 WASHC4 CENPF VPS39 HS6ST2 CNTRL FASTKD5 PPP1R7 PIGT AKAP9 GCC2 CCAR1 GIGYF2 PIBF1 PBXIP1 HEATR3 GOLGB1 NIN | 5.26e-08 | 754 | 174 | 18 | 33060197 |
| Pubmed | 7.48e-08 | 9 | 174 | 4 | 38237590 | ||
| Pubmed | Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos. | 9.26e-08 | 23 | 174 | 5 | 18083014 | |
| Pubmed | 1.16e-07 | 24 | 174 | 5 | 22333836 | ||
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 1.23e-07 | 3 | 174 | 3 | 18177668 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 24929238 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 1.23e-07 | 3 | 174 | 3 | 21874018 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 1.23e-07 | 3 | 174 | 3 | 19800316 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 1.23e-07 | 3 | 174 | 3 | 23329853 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 23665121 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 1.23e-07 | 3 | 174 | 3 | 19582141 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 18584034 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 21969378 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 20661723 | ||
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 1.23e-07 | 3 | 174 | 3 | 14728807 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 22388986 | ||
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 1.23e-07 | 3 | 174 | 3 | 30837263 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 1.23e-07 | 3 | 174 | 3 | 27939294 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 18442017 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 16790525 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 19447925 | ||
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 1.23e-07 | 3 | 174 | 3 | 30846691 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 1.23e-07 | 3 | 174 | 3 | 16259959 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 12609610 | ||
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 1.23e-07 | 3 | 174 | 3 | 24527385 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 18086680 | ||
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 1.23e-07 | 3 | 174 | 3 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 1.23e-07 | 3 | 174 | 3 | 17352742 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 1.23e-07 | 3 | 174 | 3 | 25005472 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 23071603 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 21119109 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 18290762 | ||
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 1.23e-07 | 3 | 174 | 3 | 23333380 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 25825768 | ||
| Pubmed | Nanog retrotransposed genes with functionally conserved open reading frames. | 1.23e-07 | 3 | 174 | 3 | 16845474 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 22028025 | ||
| Pubmed | Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. | 1.23e-07 | 3 | 174 | 3 | 28457890 | |
| Pubmed | Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. | 1.23e-07 | 3 | 174 | 3 | 18436640 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 26549484 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 21187909 | ||
| Pubmed | NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. | 1.23e-07 | 3 | 174 | 3 | 24462001 | |
| Pubmed | Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. | 1.23e-07 | 3 | 174 | 3 | 23103910 | |
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 1.23e-07 | 3 | 174 | 3 | 30814124 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 1.23e-07 | 3 | 174 | 3 | 26660234 | |
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 1.23e-07 | 3 | 174 | 3 | 17211451 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 15502159 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 20574542 | ||
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 1.23e-07 | 3 | 174 | 3 | 23054952 | |
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 1.23e-07 | 3 | 174 | 3 | 26975336 | |
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 1.23e-07 | 3 | 174 | 3 | 26733157 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 19703398 | ||
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 1.23e-07 | 3 | 174 | 3 | 28636920 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 20539761 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 29245050 | ||
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 1.23e-07 | 3 | 174 | 3 | 15494369 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 1.23e-07 | 3 | 174 | 3 | 21194951 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 16791199 | ||
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 1.23e-07 | 3 | 174 | 3 | 18024963 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 27125671 | ||
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 1.23e-07 | 3 | 174 | 3 | 25410303 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 33334884 | ||
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 1.23e-07 | 3 | 174 | 3 | 17360937 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 26760119 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 1.23e-07 | 3 | 174 | 3 | 24461999 | |
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 1.23e-07 | 3 | 174 | 3 | 22172669 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 1.23e-07 | 3 | 174 | 3 | 17554338 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 24227785 | ||
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 1.23e-07 | 3 | 174 | 3 | 23770853 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 17204467 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 23200040 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 16773043 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 32145514 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 1.23e-07 | 3 | 174 | 3 | 18097409 | |
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 1.23e-07 | 3 | 174 | 3 | 25753417 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 22337995 | ||
| Pubmed | Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. | 1.23e-07 | 3 | 174 | 3 | 31891567 | |
| Pubmed | Isolation and characterization of the murine Nanog gene promoter. | 1.23e-07 | 3 | 174 | 3 | 15916719 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 16313224 | ||
| Pubmed | Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6. | 1.23e-07 | 3 | 174 | 3 | 33665763 | |
| Interaction | NDC80 interactions | CCDC14 ROCK2 CEP85 CENPE IFT74 CAGE1 ICE1 CEP192 CEP63 CCDC66 AKAP9 GCC2 SYNE2 NUFIP2 PIBF1 SCLT1 HSPA4 NIN | 7.42e-11 | 312 | 162 | 18 | int:NDC80 |
| Interaction | WHAMMP3 interactions | CENPE CCDC186 SYNE1 CNTRL TSC1 CEP63 AKAP9 GCC2 KXD1 PIBF1 GOLGA1 NIN | 2.18e-10 | 119 | 162 | 12 | int:WHAMMP3 |
| Interaction | CCDC138 interactions | CCDC14 CEP85 DCTN2 CNTRL CEP63 FAM120C PIBF1 SCLT1 CEP57 PBXIP1 GOLGA1 NIN | 3.22e-10 | 123 | 162 | 12 | int:CCDC138 |
| Interaction | CEP131 interactions | CCDC14 CEP85 CENPE DCTN2 WWP2 CNTRL CEP192 CEP63 FAM120C RHOBTB2 PIBF1 SCLT1 GOLGA1 NIN | 8.68e-10 | 200 | 162 | 14 | int:CEP131 |
| Interaction | PCM1 interactions | CCDC14 CEP85 RNF31 MED29 CENPE IFT74 CNTRL TSC1 TRIM21 CEP192 CEP63 CCDC66 AKAP9 FAM120C GCC2 PIBF1 SCLT1 GOLGA1 NIN | 2.25e-09 | 434 | 162 | 19 | int:PCM1 |
| Interaction | CCDC14 interactions | CCDC14 CEP85 RNF31 CNTRL CEP192 CEP63 S100A4 CCDC66 PIBF1 SCLT1 NIN | 7.57e-09 | 129 | 162 | 11 | int:CCDC14 |
| Interaction | MED4 interactions | CCDC14 MED29 CENPE DCTN2 IFT74 WWP2 CNTRL GIT2 TRIP11 CEP63 JUN CCDC66 NUFIP2 CCAR1 MED23 PIBF1 MED27 NIN | 2.45e-08 | 450 | 162 | 18 | int:MED4 |
| Interaction | TNRC6A interactions | TNPO1 CEP85 RNF31 CNTRL TRIM21 CEP192 TRIP11 PCF11 FAM120C GIGYF2 MED23 MED27 SCLT1 NIN | 6.36e-08 | 280 | 162 | 14 | int:TNRC6A |
| Interaction | PCNT interactions | CCDC14 DCTN2 SYNE1 CNTRL CEP192 RRBP1 TRIP11 CEP63 AKAP9 PIBF1 CEP57 GOLGA1 NIN | 7.94e-08 | 241 | 162 | 13 | int:PCNT |
| Interaction | FBF1 interactions | TRAF2 CEP85 MID2 IFT74 TSC1 CEP192 NR3C1 CEP63 SPTBN5 CCDC102B SCLT1 | 1.40e-07 | 171 | 162 | 11 | int:FBF1 |
| Interaction | OFD1 interactions | CCDC14 CEP85 CENPE DCTN2 IFT74 CNTRL ICE1 CEP192 CEP63 FAM120C RABEP1 PIBF1 HSPA4 GOLGA1 NIN | 1.42e-07 | 347 | 162 | 15 | int:OFD1 |
| Interaction | PFN1 interactions | DOCK4 RAD52 MYH9 IFT74 TSC1 TRIM21 CEP192 GIT2 FCHO2 TRIP11 AKAP9 RABEP1 GCC2 SYNE2 CDH1 LRIF1 GOLGA4 GOLGB1 | 1.56e-07 | 509 | 162 | 18 | int:PFN1 |
| Interaction | PRKAR2A interactions | MYH9 PDE4A SMC4 TRIM21 AKAP4 AKAP9 GIGYF2 SCLT1 ACBD3 HSPA4 LRIF1 GOLGA4 | 1.95e-07 | 217 | 162 | 12 | int:PRKAR2A |
| Interaction | DCTN2 interactions | MED29 DCTN2 IFT74 PPP1R12A SMC4 TSC1 CEP192 ZNF518A AKAP9 RABEP1 GCC2 CCAR1 SCLT1 ACBD3 NIN | 1.97e-07 | 356 | 162 | 15 | int:DCTN2 |
| Interaction | CEP63 interactions | CCDC14 CEP85 IFT74 SYNE1 CEP192 CEP63 CCDC66 KXD1 PIBF1 CEP57 NIN | 2.23e-07 | 179 | 162 | 11 | int:CEP63 |
| Interaction | CCHCR1 interactions | TRAF2 MID2 TRIM21 GIT2 CEP63 CCDC13 RABEP1 KXD1 CCDC102B PIBF1 CEP57 NIN | 3.49e-07 | 229 | 162 | 12 | int:CCHCR1 |
| Interaction | KRT8 interactions | CCDC14 DOCK4 MYH9 CEP85 RNF31 IFT74 UBR4 CEP192 GIT2 TRIP11 AKAP9 RABEP1 PIBF1 CEP57 CDH1 NIN | 5.68e-07 | 441 | 162 | 16 | int:KRT8 |
| Interaction | SYNE3 interactions | CCDC14 DOCK4 CEP85 CENPE IFT74 LAMB1 TSC1 TRIM21 CEP192 CEP63 PIGT CCDC66 SYNE2 CCDC15 PBXIP1 NIN | 6.21e-07 | 444 | 162 | 16 | int:SYNE3 |
| Interaction | SASS6 interactions | CCDC14 CENPE NANOG UBR4 CEP192 TRIP11 CEP63 CCDC102B PIBF1 NIN | 6.51e-07 | 159 | 162 | 10 | int:SASS6 |
| Interaction | MIB1 interactions | CCDC14 IFT74 CNTRL NR3C1 FCHO2 CEP63 CCDC66 FAM120C RHOBTB2 NUFIP2 GIGYF2 PIBF1 NIN | 8.05e-07 | 295 | 162 | 13 | int:MIB1 |
| Interaction | CEP128 interactions | CCDC14 CEP85 WASHC4 MID2 IFT74 CNTRL CEP192 CEP63 S100A4 CCDC66 PIBF1 SCLT1 NIN | 8.69e-07 | 297 | 162 | 13 | int:CEP128 |
| Interaction | NINL interactions | CCDC14 CEP85 CENPE DCTN2 IFT74 LRSAM1 UTP14A SMC4 TSC1 CEP192 JUN CCDC66 GIGYF2 PIBF1 SCLT1 HSPA4 | 9.35e-07 | 458 | 162 | 16 | int:NINL |
| Interaction | CSPP1 interactions | 1.07e-06 | 96 | 162 | 8 | int:CSPP1 | |
| Interaction | ARHGEF2 interactions | ARHGAP42 FOXO3 CDC42BPA WASHC4 RNF31 WWP2 CNTRL TSC1 NR3C1 FCHO2 SCLT1 NIN | 1.14e-06 | 256 | 162 | 12 | int:ARHGEF2 |
| Interaction | TCHP interactions | 1.15e-06 | 131 | 162 | 9 | int:TCHP | |
| Interaction | BORCS6 interactions | 1.20e-06 | 170 | 162 | 10 | int:BORCS6 | |
| Interaction | KXD1 interactions | 1.20e-06 | 170 | 162 | 10 | int:KXD1 | |
| Interaction | NIN interactions | CCDC14 CENPE DCTN2 IFT74 CNTRL UTP14A CEP192 CEP63 CCDC66 KXD1 GIGYF2 PIBF1 SCLT1 NIN | 1.29e-06 | 359 | 162 | 14 | int:NIN |
| Interaction | PPP1R13B interactions | CENPF WWP2 CEP63 PPP1R7 FAM120C CCDC102B CEP57 CDH1 GOLGA1 NIN | 1.65e-06 | 176 | 162 | 10 | int:PPP1R13B |
| Interaction | KDM1A interactions | CCDC14 NCOA3 MYH9 CENPF IFT74 NANOG PPP1R12A UBR4 TSC1 TRIM21 CAGE1 ICE1 NR3C1 AKAP9 RABEP1 GCC2 GSTCD GIGYF2 MED23 SCLT1 CEP57 GOLGB1 NIN | 1.93e-06 | 941 | 162 | 23 | int:KDM1A |
| Interaction | SEPTIN10 interactions | 2.53e-06 | 144 | 162 | 9 | int:SEPTIN10 | |
| Interaction | CEP350 interactions | 3.35e-06 | 149 | 162 | 9 | int:CEP350 | |
| Interaction | ZNF774 interactions | 3.40e-06 | 79 | 162 | 7 | int:ZNF774 | |
| Interaction | CEP192 interactions | CCDC14 CEP85 DCTN2 CNTRL CEP192 CEP63 FAM120C RHOBTB2 GOLGA1 NIN | 3.60e-06 | 192 | 162 | 10 | int:CEP192 |
| Interaction | SSX2IP interactions | CCDC14 CEP85 IFT74 CNTRL CEP63 FAM120C RHOBTB2 CCAR1 PIBF1 SCLT1 GOLGA1 NIN | 3.86e-06 | 288 | 162 | 12 | int:SSX2IP |
| Interaction | TP53BP2 interactions | WWP2 CNTRL UTP14A PPP1R7 CCDC13 PIBF1 SCLT1 CDH1 HSPA4 GOLGA1 NIN | 4.16e-06 | 241 | 162 | 11 | int:TP53BP2 |
| Interaction | PIBF1 interactions | CCDC14 TRAF2 MED29 CNTRL CEP63 CCDC13 FAM120C PIBF1 GOLGA1 NIN | 5.17e-06 | 200 | 162 | 10 | int:PIBF1 |
| Interaction | LRRCC1 interactions | 5.33e-06 | 32 | 162 | 5 | int:LRRCC1 | |
| Interaction | LAMTOR1 interactions | ROCK2 CDC42BPA CCDC186 TSC1 CEP192 FCHO2 TRIP11 ATAD3A RABEP1 GCC2 NUFIP2 KXD1 ROBO1 KIRREL1 MME TUBD1 ACBD3 GOLGA4 GOLGB1 | 5.78e-06 | 722 | 162 | 19 | int:LAMTOR1 |
| Interaction | BICD1 interactions | DOCK4 CENPE DCTN2 IFT74 KIAA0232 CEP192 CCAR1 GIGYF2 PIBF1 SCLT1 NIN | 5.91e-06 | 250 | 162 | 11 | int:BICD1 |
| Interaction | WRAP73 interactions | 6.90e-06 | 123 | 162 | 8 | int:WRAP73 | |
| Interaction | KCNA3 interactions | TNPO1 ROCK2 MYH9 CDC42BPA ABCA13 SMC4 FCHO2 RRBP1 RYR1 ATAD3A NUFIP2 VPS13A GIGYF2 ROBO1 RP1 POLQ DNAH5 HSPA4 GOLGA4 GOLGB1 TBCE | 6.96e-06 | 871 | 162 | 21 | int:KCNA3 |
| Interaction | YWHAH interactions | CCDC125 DOCK4 FOXO3 NCOA3 CDC42BPA IFT74 KIAA0232 PPP1R12A CNTRL RALGPS2 TSC1 CEP192 GIT2 NR3C1 TRIP11 JUN AKAP9 RABEP1 SYNE2 GIGYF2 PIBF1 HSPA4 GOLGA4 NIN | 8.16e-06 | 1102 | 162 | 24 | int:YWHAH |
| Interaction | SYCE1 interactions | 8.74e-06 | 127 | 162 | 8 | int:SYCE1 | |
| Interaction | WDR64 interactions | 8.83e-06 | 17 | 162 | 4 | int:WDR64 | |
| Interaction | BICD2 interactions | DOCK4 FOXO3 CENPE DCTN2 UTP14A CEP192 FCHO2 PPP1R7 AKAP9 KXD1 PIBF1 DNAH5 TBCE NIN | 9.26e-06 | 426 | 162 | 14 | int:BICD2 |
| Interaction | RCOR1 interactions | MYH9 CENPF IFT74 PPP1R12A UBR4 SMC4 ICE1 GIT2 NR3C1 RABEP1 GCC2 GIGYF2 MED23 SCLT1 HSPA4 | 1.13e-05 | 494 | 162 | 15 | int:RCOR1 |
| Interaction | CEP135 interactions | CCDC14 CEP85 IFT74 CEP192 CEP63 CCDC66 AKAP9 CCDC15 PIBF1 GOLGB1 NIN | 1.31e-05 | 272 | 162 | 11 | int:CEP135 |
| Interaction | TXLNB interactions | 1.33e-05 | 97 | 162 | 7 | int:TXLNB | |
| Interaction | RAB2A interactions | CCDC125 ROCK2 CDC42BPA CNTRL TSC1 TRIP11 SGMS1 GCC2 RHOBTB2 VPS13A KIRREL1 SCLT1 ACBD3 GOLGA4 GOLGB1 NIN | 1.41e-05 | 567 | 162 | 16 | int:RAB2A |
| Interaction | UACA interactions | 1.44e-05 | 136 | 162 | 8 | int:UACA | |
| Interaction | CEP152 interactions | 1.48e-05 | 179 | 162 | 9 | int:CEP152 | |
| Interaction | EML4 interactions | 1.52e-05 | 137 | 162 | 8 | int:EML4 | |
| Interaction | PHLPP1 interactions | MYH9 CENPF SMC4 TSC1 FCHO2 RRBP1 NEB NUFIP2 GIGYF2 ROBO1 CDH1 GOLGB1 | 1.67e-05 | 333 | 162 | 12 | int:PHLPP1 |
| Interaction | PXN interactions | DOCK4 IFT74 CEP192 GIT2 TRIP11 AKAP9 GCC2 CDH1 HSPA4 GOLGA4 GOLGB1 NIN | 1.72e-05 | 334 | 162 | 12 | int:PXN |
| Interaction | GOLGA3 interactions | TRAF2 MYH9 RNF31 PPP1R12A SMC4 KXD1 CDH1 ACBD3 GOLGA1 GOLGA4 | 1.82e-05 | 231 | 162 | 10 | int:GOLGA3 |
| Interaction | TNRC6B interactions | CEP85 CNTRL CEP192 TRIP11 CEP63 FAM120C GIGYF2 MED23 PIBF1 SCLT1 NIN | 1.83e-05 | 282 | 162 | 11 | int:TNRC6B |
| Interaction | KRT19 interactions | CCDC14 CEP85 RNF31 DCTN2 IFT74 CEP192 CEP63 AKAP9 GCC2 PIBF1 NIN | 1.83e-05 | 282 | 162 | 11 | int:KRT19 |
| Interaction | ATG16L1 interactions | CCDC14 CEP85 WASHC4 MED29 PPP1R12A CNTRL SMC4 TSC1 CEP192 GIT2 NR3C1 TRIP11 CEP63 RABEP1 GCC2 NUFIP2 KXD1 CCAR1 ROBO1 KIRREL1 CCDC102B MED27 HSPA4 GOLGB1 | 1.93e-05 | 1161 | 162 | 24 | int:ATG16L1 |
| Interaction | ENTR1 interactions | 2.19e-05 | 188 | 162 | 9 | int:ENTR1 | |
| Interaction | CEP43 interactions | 2.38e-05 | 190 | 162 | 9 | int:CEP43 | |
| Interaction | ATXN7 interactions | 2.85e-05 | 109 | 162 | 7 | int:ATXN7 | |
| Interaction | ATG12 interactions | KIF18A TRAF2 RNF31 VPS39 ATXN7L3 GCC2 KXD1 VPS13A MED23 GOLGA4 GOLGB1 | 2.86e-05 | 296 | 162 | 11 | int:ATG12 |
| Interaction | FBXO22 interactions | CENPE CENPF PPP1R12A LRSAM1 SMC4 TSC1 TRIM21 RRBP1 NEB CCAR1 GIGYF2 RP1 ATP2A3 GOLGA1 ZNF292 | 3.18e-05 | 540 | 162 | 15 | int:FBXO22 |
| Interaction | TMT1A interactions | SYNE1 NR3C1 RRBP1 TRIP11 GCC2 SYNE2 VPS13A MME ACBD3 PBXIP1 GOLGA4 GOLGB1 | 3.49e-05 | 359 | 162 | 12 | int:TMT1A |
| Interaction | PLK4 interactions | 3.54e-05 | 154 | 162 | 8 | int:PLK4 | |
| Interaction | RAB11A interactions | ROCK2 MYH9 CDC42BPA DCTN2 TSC1 RILPL1 NR3C1 RRBP1 TRIP11 RABEP1 GCC2 SYNE2 VPS13A ROBO1 KIRREL1 MME ACBD3 GOLGA4 GOLGB1 | 4.00e-05 | 830 | 162 | 19 | int:RAB11A |
| Interaction | ODF2 interactions | 4.25e-05 | 158 | 162 | 8 | int:ODF2 | |
| Interaction | SFN interactions | CCDC125 FOXO3 CDC42BPA KIAA0232 PPP1R12A RALGPS2 TRIM21 CEP192 NR3C1 NEB TRIP11 PIGT AKAP9 CCAR1 CCDC102B CTSD CDH1 | 4.39e-05 | 692 | 162 | 17 | int:SFN |
| Interaction | STX4 interactions | CDC42BPA CENPF VPS39 SYNE1 TRIP11 SYNE2 VPS13A ROBO1 KIRREL1 CDH1 ACBD3 GOLGA4 GOLGB1 | 4.42e-05 | 428 | 162 | 13 | int:STX4 |
| Interaction | DISC1 interactions | DCTN2 IFT74 SYNE1 RRBP1 TRIP11 CEP63 CCDC13 AKAP9 CCDC102B PIBF1 CTSD CEP57 PBXIP1 | 4.52e-05 | 429 | 162 | 13 | int:DISC1 |
| Interaction | H2BC21 interactions | TNPO1 ROCK2 UBQLN1 ATRX CENPF DCTN2 IFT74 WWP2 PARP2 LAMB1 NEB ATXN7L3 SGO2 MED27 DNAH5 LRIF1 ZNF292 | 4.72e-05 | 696 | 162 | 17 | int:H2BC21 |
| Interaction | TUBB4B interactions | TNPO1 MYH9 RNF31 MID2 DCTN2 NANOG PPP1R12A CNTRL UBR4 TRIM21 NR3C1 GCC2 CDH1 TBCE NIN | 4.81e-05 | 560 | 162 | 15 | int:TUBB4B |
| Interaction | FBXO42 interactions | ROCK2 DOCK4 CEP85 CENPE TSC1 CEP192 GIT2 NR3C1 TRIP11 GOLGB1 | 4.83e-05 | 259 | 162 | 10 | int:FBXO42 |
| Interaction | TMOD1 interactions | 4.86e-05 | 161 | 162 | 8 | int:TMOD1 | |
| Interaction | CLEC4D interactions | TNPO1 MYH9 HS6ST2 UBR4 TMOD2 TRIP11 ATAD3A SYNE2 ACBD3 GOLGB1 | 5.15e-05 | 261 | 162 | 10 | int:CLEC4D |
| Interaction | LZTS1 interactions | 5.29e-05 | 120 | 162 | 7 | int:LZTS1 | |
| Interaction | YWHAZ interactions | CCDC125 FOXO3 RAD52 TRAF2 MYH9 CDC42BPA HS6ST2 KIAA0232 PPP1R12A WWP2 RALGPS2 TSC1 TRIM21 CEP192 NEB AKAP9 RABEP1 GCC2 SYNE2 GIGYF2 CTSD CDH1 HSPA4 GP5 NIN | 5.34e-05 | 1319 | 162 | 25 | int:YWHAZ |
| Interaction | CEP170 interactions | RNF31 IFT74 STK17A CNTRL S100A4 TEKT2 AKAP9 SYNE2 SCLT1 CEP57 NIN | 5.48e-05 | 318 | 162 | 11 | int:CEP170 |
| Interaction | EXOC4 interactions | 5.82e-05 | 213 | 162 | 9 | int:EXOC4 | |
| Interaction | WASHC2A interactions | 5.88e-05 | 122 | 162 | 7 | int:WASHC2A | |
| Interaction | GCC2 interactions | 6.20e-05 | 123 | 162 | 7 | int:GCC2 | |
| Interaction | INSYN1 interactions | 6.84e-05 | 169 | 162 | 8 | int:INSYN1 | |
| Interaction | CCDC85C interactions | 6.86e-05 | 125 | 162 | 7 | int:CCDC85C | |
| Interaction | RHOH interactions | ROCK2 CDC42BPA WWP2 UTP14A TSC1 TRIP11 ATAD3A VPS13A ROBO1 KIRREL1 ACBD3 LRIF1 GOLGA4 GOLGB1 | 6.96e-05 | 512 | 162 | 14 | int:RHOH |
| Interaction | ZFPL1 interactions | CDC42BPA MTERF3 FCHO2 CPLX4 TRIP11 GCC2 ROBO1 KIRREL1 ATP2A3 ACBD3 PBXIP1 GOLGA4 GOLGB1 | 7.02e-05 | 448 | 162 | 13 | int:ZFPL1 |
| Interaction | ZNF250 interactions | 7.22e-05 | 126 | 162 | 7 | int:ZNF250 | |
| Interaction | MAPRE1 interactions | TRAF2 CENPE DCTN2 PPP1R12A UTP14A RRBP1 JUN AKAP9 GCC2 GIGYF2 PIBF1 CDH1 GOLGA1 NIN | 7.25e-05 | 514 | 162 | 14 | int:MAPRE1 |
| Interaction | SPATA2 interactions | 7.26e-05 | 87 | 162 | 6 | int:SPATA2 | |
| Interaction | SYT17 interactions | 7.26e-05 | 54 | 162 | 5 | int:SYT17 | |
| Interaction | APC interactions | CEP85 RNF31 SYNE1 TRIM21 ZNF510 NEB JUN FAM120C GIGYF2 RP1 GOLGA1 NIN | 7.54e-05 | 389 | 162 | 12 | int:APC |
| Interaction | TRIM33 interactions | TNPO1 NCOA3 TRAF2 MYH9 RNF31 NANOG SMC4 TRIM21 RRBP1 JUN HSPA4 GOLGB1 NIN | 7.85e-05 | 453 | 162 | 13 | int:TRIM33 |
| Interaction | HDAC1 interactions | MYH9 CDC42BPA ATRX CENPF IFT74 NANOG WWP2 PARP2 UBR4 SMC4 TRIM21 NR3C1 JUN AKAP9 RABEP1 GCC2 SYNE2 GIGYF2 CDH1 HSPA4 GOLGA4 GOLGB1 | 8.05e-05 | 1108 | 162 | 22 | int:HDAC1 |
| Interaction | TBC1D31 interactions | 8.66e-05 | 56 | 162 | 5 | int:TBC1D31 | |
| Interaction | RAB9A interactions | TRAF2 WASHC4 CNTRL TSC1 RRBP1 TRIP11 RABEP1 GCC2 RHOBTB2 SYNE2 KXD1 VPS13A ACBD3 GOLGA4 GOLGB1 | 9.48e-05 | 595 | 162 | 15 | int:RAB9A |
| Interaction | IFT57 interactions | 1.05e-04 | 93 | 162 | 6 | int:IFT57 | |
| Interaction | GAPVD1 interactions | 1.06e-04 | 180 | 162 | 8 | int:GAPVD1 | |
| Interaction | PHF21A interactions | CENPF IFT74 UBR4 ICE1 GIT2 JUN RABEP1 GCC2 GIGYF2 SCLT1 GOLGB1 | 1.07e-04 | 343 | 162 | 11 | int:PHF21A |
| Interaction | RYBP interactions | 1.12e-04 | 232 | 162 | 9 | int:RYBP | |
| Interaction | MPHOSPH9 interactions | 1.18e-04 | 95 | 162 | 6 | int:MPHOSPH9 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.95e-05 | 181 | 105 | 7 | 694 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.99e-04 | 4 | 105 | 2 | 1252 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 6.23e-04 | 29 | 105 | 3 | 396 | |
| GeneFamily | Cyclins|Mediator complex | 9.15e-04 | 33 | 105 | 3 | 1061 | |
| GeneFamily | Laminin subunits | 2.12e-03 | 12 | 105 | 2 | 626 | |
| GeneFamily | Myosin heavy chains | 3.34e-03 | 15 | 105 | 2 | 1098 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TNPO1 KIF18A CDC42BPA CENPE IFT74 MTERF3 SMC4 CEP192 TRIP11 CEP63 PIEZO2 RABEP1 GCC2 SYNE2 CCAR1 PIBF1 POLQ CEP57 CDH1 GOLGA4 GOLGB1 NIN | 2.04e-10 | 656 | 166 | 22 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 DOCK4 FOXO3 NCOA3 CDC42BPA WASHC4 ATRX CENPE CENPF PPP1R12A NR3C1 PCF11 JUN SGMS1 AKAP9 GCC2 SYNE2 VPS13A GIGYF2 PIBF1 ACBD3 GOLGA4 ZNF292 | 5.41e-09 | 856 | 166 | 23 | M4500 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | DOCK4 MYH9 CDC42BPA CENPE CENPF CNTRL SMC4 TSC1 CEP192 TUBD1 CEP57 NIN | 5.77e-09 | 199 | 166 | 12 | M5893 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ROCK2 FOXO3 NCOA3 CDC42BPA WASHC4 ATRX CENPE CENPF PPP1R12A NR3C1 JUN AKAP9 VPS13A GIGYF2 PIBF1 GOLGA4 ZNF292 | 7.77e-09 | 466 | 166 | 17 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | ROCK2 DOCK4 MYH9 CDC42BPA SYNE1 PPP1R12A LAMA2 JUN PIEZO2 AKAP9 ROBO1 | 1.86e-08 | 177 | 166 | 11 | M39245 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 1.00e-07 | 164 | 166 | 10 | M19957 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | DOCK4 FOXO3 NCOA3 ATRX CENPF KIAA0232 PPP1R12A SMC4 ICE1 PCF11 AKAP9 VPS13A | 5.15e-07 | 300 | 166 | 12 | M8702 |
| Coexpression | GSE14308_TH17_VS_INDUCED_TREG_UP | 6.32e-07 | 200 | 166 | 10 | M3385 | |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 7.38e-07 | 12 | 166 | 4 | M34000 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | NCOA3 PDE4C ANGPT1 IFT74 WWP2 LAMA2 S100A4 AKAP9 RABEP1 TLR1 PIBF1 TUBD1 GOLGA4 | 1.29e-06 | 389 | 166 | 13 | M6520 |
| Coexpression | FISCHER_DREAM_TARGETS | CCDC14 KIF18A CEP85 CENPE CENPF PARP2 SMC4 CEP192 ZNF518A PCF11 ATAD3A NUFIP2 CEP83 GSTCD CCDC15 SGO2 POLQ SCLT1 TUBD1 CEP57 | 3.59e-06 | 969 | 166 | 20 | M149 |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_UP | 5.52e-06 | 200 | 166 | 9 | M3378 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | NCOA3 UBQLN1 CDC42BPA ATRX TMOD2 NR3C1 TRIP11 GPR158 RABEP1 GCC2 SYNE2 GIGYF2 ROBO1 DNAH5 ATP2A3 GOLGA4 GOLGB1 ZNF292 NIN | 9.42e-06 | 946 | 166 | 19 | M39169 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | KIF18A WASHC4 ATRX CENPE CENPF STK17A RALGPS2 SMC4 CEP63 MBNL2 GPR158 SGO2 MME CEP57 HSPA4 LRIF1 | 1.49e-05 | 721 | 166 | 16 | M10237 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE | 1.59e-05 | 84 | 166 | 6 | M40895 | |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 2.08e-05 | 236 | 166 | 9 | M130 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.36e-05 | 90 | 166 | 6 | M39250 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 2.90e-05 | 10 | 166 | 3 | MM741 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CCDC14 KIF18A TRAF2 CEP85 MED29 CENPE CENPF PARP2 CNTRL CEP192 RBM23 CEP63 SYNE2 CCDC15 SGO2 POLQ TUBD1 NIN | 3.03e-05 | 939 | 166 | 18 | M45768 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 3.47e-05 | 194 | 166 | 8 | M7467 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN | 3.73e-05 | 196 | 166 | 8 | M5008 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 3.87e-05 | 197 | 166 | 8 | M5378 | |
| Coexpression | GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP | 4.15e-05 | 199 | 166 | 8 | M9754 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 6.10e-05 | 155 | 166 | 7 | M39246 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | TNPO1 ROCK2 ANGPT1 CDC42BPA MED29 CENPE LRSAM1 UBR4 TRIM21 RRBP1 CEP63 S100A4 KXD1 PLCB3 HEATR3 | 8.50e-05 | 746 | 166 | 15 | M40863 |
| Coexpression | MIKKELSEN_PLURIPOTENT_STATE_UP | 8.63e-05 | 14 | 166 | 3 | MM810 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 9.23e-05 | 223 | 166 | 8 | M17621 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 9.95e-05 | 289 | 166 | 9 | M2196 | |
| Coexpression | WHITEFORD_PEDIATRIC_CANCER_MARKERS | 1.03e-04 | 117 | 166 | 6 | M7854 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | DOCK4 FOXO3 STK17A CCDC186 WWP2 SMC4 CCDC66 MBNL2 GIGYF2 MME MED23 PBXIP1 GOLGA4 ZNF292 | 1.15e-04 | 680 | 166 | 14 | M41089 |
| Coexpression | ZHONG_PFC_C1_OPC | 1.45e-04 | 238 | 166 | 8 | M39096 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_UP | 1.76e-04 | 245 | 166 | 8 | M7300 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN | 1.84e-04 | 185 | 166 | 7 | M8824 | |
| Coexpression | PGF_UP.V1_UP | 2.16e-04 | 190 | 166 | 7 | M2674 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | IFT74 UBR4 MTERF3 PCF11 JUN MBNL2 RABEP1 PIBF1 CEP57 PBXIP1 HEATR3 | 2.43e-04 | 477 | 166 | 11 | M40930 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | TNPO1 WASHC4 ATRX IFT74 PPP1R12A PARP2 CNTRL MTERF3 TSC1 NR3C1 RRBP1 TRIP11 CEP63 MBNL2 SYNE2 CEP57 HSPA4 PBXIP1 GOLGA4 | 2.63e-04 | 1215 | 166 | 19 | M41122 |
| Coexpression | ERBB2_UP.V1_DN | 2.70e-04 | 197 | 166 | 7 | M2635 | |
| Coexpression | GSE3982_MAC_VS_BCELL_DN | 2.70e-04 | 197 | 166 | 7 | M5495 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 2.87e-04 | 199 | 166 | 7 | M3417 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 2.87e-04 | 199 | 166 | 7 | M9253 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP | 2.96e-04 | 200 | 166 | 7 | M8042 | |
| Coexpression | GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP | 2.96e-04 | 200 | 166 | 7 | M5800 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 2.96e-04 | 200 | 166 | 7 | M7495 | |
| Coexpression | GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP | 2.96e-04 | 200 | 166 | 7 | M6456 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP | 2.96e-04 | 200 | 166 | 7 | M6664 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ROCK2 KIF18A ATRX CENPE CENPF GIN1 IFT74 SMC4 ZNF518A CCDC66 AKAP9 RABEP1 GCC2 SYNE2 CEP83 CCAR1 CCDC15 PIBF1 POLQ HSPA4 GOLGA4 ZNF292 | 2.70e-15 | 311 | 162 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | ROCK2 KIF18A ATRX CENPE CENPF UTP14A SMC4 AKAP9 RABEP1 SYNE2 CEP83 CCAR1 PIBF1 POLQ HSPA4 GOLGA4 | 1.68e-12 | 192 | 162 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 KIF18A RNF31 ATRX CENPE CENPF GIN1 IFT74 UTP14A SMC4 GIT2 ZNF518A CEP63 PIGT CCDC66 AKAP9 RABEP1 SYNE2 KXD1 CEP83 VPS13A CCAR1 CCDC15 PIBF1 POLQ HSPA4 GOLGA1 GOLGA4 ZNF292 | 6.28e-12 | 831 | 162 | 29 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ROCK2 KIF18A ATRX CENPE CENPF SMC4 CEP192 FCHO2 ZNF518A PCF11 JUN AKAP9 RABEP1 CEP83 CCAR1 GIGYF2 SGO2 PIBF1 SCLT1 CEP57 HSPA4 ZNF292 | 1.07e-11 | 469 | 162 | 22 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ROCK2 KIF18A WASHC4 ATRX CENPE CENPF GIN1 IFT74 UTP14A SMC4 ZNF518A CEP63 CCDC66 AKAP9 RABEP1 GCC2 SYNE2 CEP83 GSTCD VPS13A CCAR1 CCDC15 PIBF1 POLQ CDH1 HSPA4 LRIF1 GOLGA4 ZNF292 | 3.92e-10 | 989 | 162 | 29 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ROCK2 ANGPT1 ATRX CENPE CCDC186 SYNE1 PPP1R12A RALGPS2 SMC4 S100A4 JUN CCDC66 GCC2 CEP83 CCAR1 SCLT1 HSPA4 GOLGB1 ZNF292 | 8.91e-10 | 432 | 162 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NCOA3 RNF31 ATRX CENPE CENPF GIN1 IFT74 CCDC186 RALGPS2 SMC4 TSC1 GIT2 JUN PIGT CCDC66 AKAP9 GCC2 SYNE2 KXD1 VPS13A CCAR1 ACBD3 HSPA4 GOLGA1 NIN | 1.24e-09 | 780 | 162 | 25 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ROCK2 KIF18A CENPE CENPF UTP14A SMC4 CEP192 ZNF518A CEP63 PCF11 PPP1R7 RABEP1 CEP83 GIGYF2 SGO2 PIBF1 POLQ SCLT1 CEP57 HSPA4 | 4.62e-09 | 532 | 162 | 20 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ROCK2 UBQLN1 ANGPT1 ATRX CENPE CENPF CCDC186 SYNE1 PPP1R12A MTERF3 RALGPS2 SMC4 FCHO2 S100A4 JUN CCDC66 AKAP9 GCC2 SYNE2 CEP83 CCAR1 SCLT1 ACBD3 HSPA4 LRIF1 GOLGB1 ZNF292 | 7.88e-09 | 989 | 162 | 27 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | ROCK2 KIF18A WASHC4 ATRX CENPE CENPF UTP14A SMC4 CEP63 AKAP9 RABEP1 SYNE2 CEP83 CCAR1 PIBF1 POLQ CDH1 HSPA4 GOLGA4 | 9.12e-09 | 498 | 162 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ARHGAP42 ROCK2 KIF18A ATRX CENPE CENPF GIN1 IFT74 HS6ST2 CCDC186 CNTRL SMC4 FASTKD5 CEP192 FCHO2 TDRD1 ZNF518A CCDC66 AKAP9 GCC2 CEP83 CCAR1 SGO2 PIBF1 SCLT1 CEP57 ZNF281 HSPA4 LRIF1 ZNF292 | 1.67e-08 | 1241 | 162 | 30 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ARHGAP42 ROCK2 KIF18A ANGPT1 ATRX CENPE CENPF IFT74 CCDC186 CNTRL SMC4 TMOD2 TSC1 CEP192 FCHO2 ZNF518A CCDC66 AKAP9 RABEP1 GCC2 SYNE2 CEP83 VPS13A CCAR1 SGO2 SCLT1 ZNF281 HSPA4 LRIF1 ZNF292 | 2.03e-08 | 1252 | 162 | 30 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | CENPE GIN1 SMC4 CEP192 CCDC66 AKAP9 GCC2 CEP83 CCAR1 SGO2 PIBF1 HSPA4 | 2.05e-08 | 186 | 162 | 12 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | ATRX CENPE CENPF RALGPS2 SMC4 CCDC66 AKAP9 GCC2 SYNE2 CCAR1 ACBD3 HSPA4 | 2.92e-08 | 192 | 162 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | ATRX CENPE CENPF GIN1 RALGPS2 SMC4 JUN CCDC66 AKAP9 GCC2 CCAR1 ACBD3 HSPA4 NIN | 5.43e-08 | 291 | 162 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 ATRX CENPE CENPF PPP1R12A RALGPS2 SMC4 JUN CCDC66 AKAP9 SYNE2 CEP83 CCAR1 CCDC15 MED23 SCLT1 ACBD3 HSPA4 GOLGB1 ZNF292 | 7.42e-08 | 629 | 162 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | KIF18A ATRX CENPE CENPF GIN1 IFT74 CNTRL SMC4 TMOD2 CEP192 TDRD1 CCDC66 AKAP9 RABEP1 GCC2 SYNE2 CEP83 VPS13A CCAR1 CCDC15 SGO2 SCLT1 ZNF281 HSPA4 LRIF1 ZNF292 | 1.30e-07 | 1060 | 162 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ROCK2 KIF18A ATRX CENPE CENPF GIN1 IFT74 CNTRL SMC4 FASTKD5 CEP192 CCDC66 AKAP9 RABEP1 GCC2 SYNE2 CEP83 VPS13A CCAR1 SGO2 PIBF1 SCLT1 CEP57 ZNF281 HSPA4 LRIF1 FDXACB1 ZNF292 | 2.92e-07 | 1257 | 162 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | ROCK2 ANGPT1 CENPE CCDC186 SYNE1 SMC4 FCHO2 S100A4 CCDC66 GCC2 CCAR1 HSPA4 | 6.35e-07 | 255 | 162 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ARHGAP42 ROCK2 KIF18A ATRX CENPE CENPF GIN1 IFT74 HS6ST2 CCDC186 CNTRL SMC4 FASTKD5 CEP192 FCHO2 TDRD1 ZNF518A CCDC66 AKAP9 GCC2 CEP83 CCAR1 SGO2 PIBF1 SCLT1 CEP57 ZNF281 HSPA4 LRIF1 ZNF292 | 6.43e-07 | 1468 | 162 | 30 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | ARHGAP42 KIF18A MYH9 WASHC4 ATRX CCDC186 PPP1R12A LAMB1 AKAP9 VPS13A GIGYF2 MME GOLGA1 ZNF292 | 1.17e-06 | 375 | 162 | 14 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | WASHC4 ATRX CENPE CENPF RALGPS2 SMC4 LAMA2 JUN CCDC66 AKAP9 GCC2 SYNE2 CCAR1 MME ACBD3 HSPA4 | 1.21e-06 | 492 | 162 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ROCK2 KIF18A ATRX CENPE CENPF GIN1 IFT74 CNTRL SMC4 FASTKD5 CEP192 CCDC66 AKAP9 RABEP1 GCC2 SYNE2 CEP83 VPS13A CCAR1 SGO2 PIBF1 SCLT1 CEP57 ZNF281 ATP2A3 HSPA4 LRIF1 FDXACB1 ZNF292 | 1.78e-06 | 1459 | 162 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | ATRX CENPE CCDC186 SMC4 FCHO2 RABEP1 GCC2 CEP83 SGO2 SCLT1 HSPA4 GOLGB1 | 3.23e-06 | 298 | 162 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | KIF18A CDC42BPA WASHC4 CENPE CENPF GIN1 SMC4 NR3C1 S100A4 TEKT2 CCDC66 AKAP9 RABEP1 GCC2 SYNE2 CEP83 VPS13A CCAR1 MME POLQ CEP57 HSPA4 | 5.90e-06 | 983 | 162 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | KIF18A CENPE SMC4 S100A4 CCDC66 RABEP1 GCC2 CEP83 CCAR1 HSPA4 | 2.01e-05 | 246 | 162 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | WASHC4 ATRX CENPE CENPF GIN1 RALGPS2 SMC4 LAMA2 JUN CCDC66 CLEC4F AKAP9 GCC2 SYNE2 CCAR1 MME CTSD ACBD3 HSPA4 LRIF1 NIN | 2.03e-05 | 985 | 162 | 21 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | KIF18A ATRX CENPE CENPF GIN1 IFT74 CNTRL SMC4 TMOD2 CEP192 TDRD1 CCDC66 AKAP9 RABEP1 GCC2 SYNE2 CEP83 VPS13A CCAR1 CCDC15 SGO2 SCLT1 ZNF281 HSPA4 LRIF1 ZNF292 | 2.57e-05 | 1414 | 162 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | ROCK2 ANGPT1 CENPE CCDC186 SYNE1 SMC4 FCHO2 S100A4 CCDC66 AKAP9 GCC2 CCAR1 HSPA4 LRIF1 | 2.59e-05 | 492 | 162 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | CENPE GIN1 CCDC186 SMC4 CEP192 CCDC66 CLEC4F AKAP9 GCC2 CEP83 CCAR1 SGO2 PIBF1 HSPA4 | 2.59e-05 | 492 | 162 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | KIF18A CDC42BPA CENPE CENPF GIN1 SMC4 NEB CCDC66 AKAP9 RABEP1 SYNE2 CEP83 VPS13A POLQ CEP57 HSPA4 | 4.24e-05 | 654 | 162 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | KIF18A MYH9 ATRX CENPE CENPF CNTRL LAMB1 AKAP9 GIGYF2 MME GOLGA4 | 6.12e-05 | 339 | 162 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ARHGAP42 ANGPT1 CENPE CENPF HS6ST2 RALGPS2 LAMA2 LAMB1 CEP192 S100A4 TEKT2 PIEZO2 ROBO1 SGO2 MME MED27 ADGRL3 | 9.62e-05 | 777 | 162 | 17 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.06e-04 | 98 | 162 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | KIF18A PDE4A CEP85 CDC42BPA ATRX CENPE CENPF IFT74 SMCO1 CNTRL SMC4 TMOD2 TSC1 TRIM21 CCDC66 AKAP9 GCC2 SYNE2 CEP83 GSTCD VPS13A CCDC15 SCLT1 HSPA4 | 1.16e-04 | 1370 | 162 | 24 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.63e-04 | 151 | 162 | 7 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.69e-04 | 152 | 162 | 7 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.71e-04 | 203 | 162 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | CENPE GIN1 CCDC186 SMC4 CEP192 NR3C1 S100A4 TEKT2 CCDC66 CLEC4F AKAP9 GCC2 CEP83 CCAR1 SGO2 MME PIBF1 HSPA4 ADGRL3 | 1.74e-04 | 978 | 162 | 19 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ATRX CENPE CCDC186 SYNE1 SMC4 LAMA2 S100A4 CCDC66 PIEZO2 RABEP1 GCC2 CEP83 SGO2 MME SCLT1 HSPA4 | 1.89e-04 | 744 | 162 | 16 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.11e-04 | 71 | 162 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.43e-04 | 271 | 162 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.91e-04 | 166 | 162 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | ARHGAP42 KIF18A MYH9 ANGPT1 WASHC4 ATRX CCDC186 PPP1R12A LAMB1 AKAP9 VPS13A GIGYF2 MME CDH1 GOLGA1 ZNF292 | 2.94e-04 | 774 | 162 | 16 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.66e-04 | 123 | 162 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ARHGAP42 DOCK4 KIF18A CENPE CENPF HS6ST2 RALGPS2 LAMA2 LAMB1 CEP192 S100A4 TEKT2 ROBO1 SGO2 MME ADGRL3 | 3.84e-04 | 793 | 162 | 16 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 4.20e-04 | 232 | 162 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | ROCK2 WASHC4 ATRX MID2 CENPE CENPF SMC4 CEP63 AKAP9 GCC2 SYNE2 CEP83 GSTCD CCAR1 PIBF1 CDH1 HSPA4 ZNF292 | 5.46e-04 | 986 | 162 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | ARHGAP42 CDC42BPA LAMA2 LAMB1 COL6A5 JUN CD36 SYNE2 ROBO1 KIRREL1 MME | 6.37e-04 | 445 | 162 | 11 | GSM777043_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | CENPE CCDC186 SYNE1 SMC4 LAMA2 CEP192 S100A4 CCDC66 PIEZO2 GCC2 CEP83 CCAR1 SGO2 PIBF1 HSPA4 TBCE | 6.63e-04 | 834 | 162 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200 | 7.67e-04 | 54 | 162 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | ROCK2 ATRX CENPE SYNE1 SMC4 LAMA2 MBNL2 GCC2 CEP83 CCAR1 PIBF1 HSPA4 ZNF292 | 7.96e-04 | 607 | 162 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | KIF18A MYH9 WASHC4 ATRX CCDC186 SYNE1 PPP1R12A LAMA2 TMOD2 NR3C1 AKAP9 VPS13A GIGYF2 SGO2 PLCB3 | 8.62e-04 | 772 | 162 | 15 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#2_top-relative-expression-ranked_500 | 8.81e-04 | 56 | 162 | 4 | gudmap_developingKidney_e15.5_Proximal Tubules_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 9.09e-04 | 201 | 162 | 7 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1 | CCDC125 IL12A KIF18A ANGPT1 CENPE CENPF ABCA13 SYNE1 CLEC12A SGO2 | 9.36e-04 | 395 | 162 | 10 | GSM538351_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 9.91e-04 | 204 | 162 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 1.07e-03 | 101 | 162 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | CDC42BPA ATRX CENPF CCDC186 CNTRL SMC4 TRIP11 AKAP9 RABEP1 GCC2 SYNE2 GOLGA4 GOLGB1 | 7.28e-13 | 198 | 168 | 13 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | ROCK2 CDC42BPA ATRX CCDC186 TRIP11 SGMS1 AKAP9 GCC2 SYNE2 ZNF281 GOLGA4 GOLGB1 ZNF292 | 7.77e-13 | 199 | 168 | 13 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | CDC42BPA ATRX CCDC186 CNTRL TRIP11 AKAP9 GCC2 SYNE2 DNAH5 GOLGA4 GOLGB1 ZNF292 | 1.55e-11 | 199 | 168 | 12 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ROCK2 ATRX CNTRL NR3C1 FCHO2 RRBP1 TRIP11 JUN GCC2 NUFIP2 GOLGA4 | 1.22e-10 | 184 | 168 | 11 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | ROCK2 CDC42BPA CCDC186 TRIP11 JUN AKAP9 GCC2 SYNE2 GOLGB1 ZNF292 | 1.32e-10 | 138 | 168 | 10 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | ROCK2 ATRX CCDC186 TRIP11 AKAP9 RABEP1 GCC2 SYNE2 GOLGA4 GOLGB1 ZNF292 | 2.83e-10 | 199 | 168 | 11 | 19674e1eaeb51e4196d847cb62aa437c852951d3 |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-09 | 182 | 168 | 10 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-09 | 185 | 168 | 10 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | ATRX STK17A RALGPS2 JUN CCDC66 MBNL2 GCC2 SYNE2 PBXIP1 ZNF292 | 3.85e-09 | 195 | 168 | 10 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | ROCK2 ATRX CCDC186 TRIP11 AKAP9 GCC2 SYNE2 GOLGA4 GOLGB1 ZNF292 | 4.68e-09 | 199 | 168 | 10 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | CDC42BPA ATRX CCDC186 TRIP11 AKAP9 GCC2 SYNE2 GOLGA4 GOLGB1 ZNF292 | 4.68e-09 | 199 | 168 | 10 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | ROCK2 ATRX CCDC186 TRIP11 AKAP9 GCC2 SYNE2 GOLGA4 GOLGB1 ZNF292 | 4.68e-09 | 199 | 168 | 10 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-08 | 178 | 168 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 4.73e-08 | 135 | 168 | 8 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-08 | 191 | 168 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-08 | 191 | 168 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-08 | 191 | 168 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.36e-08 | 193 | 168 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.36e-08 | 193 | 168 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-08 | 194 | 168 | 9 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.60e-08 | 194 | 168 | 9 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-08 | 195 | 168 | 9 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.12e-08 | 196 | 168 | 9 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.39e-08 | 197 | 168 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.39e-08 | 197 | 168 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | CDC42BPA CCDC186 CNTRL TRIP11 AKAP9 GCC2 SYNE2 GOLGA4 GOLGB1 | 6.97e-08 | 199 | 168 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 6.97e-08 | 199 | 168 | 9 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.97e-08 | 199 | 168 | 9 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-07 | 154 | 168 | 8 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 5.11e-07 | 184 | 168 | 8 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 5.11e-07 | 184 | 168 | 8 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.55e-07 | 186 | 168 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-07 | 187 | 168 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-07 | 187 | 168 | 8 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.26e-07 | 189 | 168 | 8 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.52e-07 | 190 | 168 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.52e-07 | 190 | 168 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-07 | 191 | 168 | 8 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-07 | 191 | 168 | 8 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-07 | 191 | 168 | 8 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.05e-07 | 192 | 168 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.05e-07 | 192 | 168 | 8 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.34e-07 | 193 | 168 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.34e-07 | 193 | 168 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 7.63e-07 | 194 | 168 | 8 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.63e-07 | 194 | 168 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | ARHGAP42 ROCK2 PPP1R12A ANKRD62 ADCY3 KIRREL1 CCDC102B ADGRL3 | 8.24e-07 | 196 | 168 | 8 | 754a3613340932563cd8424d775e18b93c3a1aaa |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.24e-07 | 196 | 168 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.24e-07 | 199 | 168 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.24e-07 | 199 | 168 | 8 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.59e-07 | 200 | 168 | 8 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-07 | 200 | 168 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.59e-07 | 200 | 168 | 8 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.59e-07 | 200 | 168 | 8 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-06 | 151 | 168 | 7 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-06 | 151 | 168 | 7 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-06 | 165 | 168 | 7 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-06 | 165 | 168 | 7 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-06 | 169 | 168 | 7 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-06 | 169 | 168 | 7 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-06 | 170 | 168 | 7 | 2d5e56eee0c3ce75a9641cc14dee0e0807141c32 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 174 | 168 | 7 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-06 | 175 | 168 | 7 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-06 | 175 | 168 | 7 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 176 | 168 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 178 | 168 | 7 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 178 | 168 | 7 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.21e-06 | 178 | 168 | 7 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 179 | 168 | 7 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-06 | 179 | 168 | 7 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 181 | 168 | 7 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.81e-06 | 181 | 168 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 181 | 168 | 7 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 6.25e-06 | 183 | 168 | 7 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.47e-06 | 184 | 168 | 7 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.47e-06 | 184 | 168 | 7 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 6.47e-06 | 184 | 168 | 7 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.47e-06 | 184 | 168 | 7 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.47e-06 | 184 | 168 | 7 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-06 | 185 | 168 | 7 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-06 | 185 | 168 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-06 | 185 | 168 | 7 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-06 | 185 | 168 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-06 | 185 | 168 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue | 6.95e-06 | 186 | 168 | 7 | e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.95e-06 | 186 | 168 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.95e-06 | 186 | 168 | 7 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.20e-06 | 187 | 168 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.20e-06 | 187 | 168 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.20e-06 | 187 | 168 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.20e-06 | 187 | 168 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.20e-06 | 187 | 168 | 7 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.20e-06 | 187 | 168 | 7 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.20e-06 | 187 | 168 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-06 | 188 | 168 | 7 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.45e-06 | 188 | 168 | 7 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | MYH9 ATRX SYNE1 AKAP9 GCC2 SYNE2 NUFIP2 GOLGA4 GOLGB1 ZNF292 | 1.52e-11 | 49 | 98 | 10 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.01e-06 | 49 | 98 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.70e-05 | 50 | 98 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.70e-05 | 50 | 98 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1 | |
| Computational | Spindle and kinetochore. | 3.78e-04 | 16 | 98 | 3 | MODULE_315 | |
| Drug | nocodazole | ROCK2 MYH9 DCTN2 PPP1R12A SEC31B JUN AKAP9 CCAR1 CTSD TUBD1 CEP57 CDH1 HSPA4 GOLGA1 GOLGA4 GOLGB1 TBCE NIN | 1.27e-08 | 477 | 165 | 18 | CID000004122 |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | KIF18A TRAF2 PDE4A CENPE CENPF CCDC186 GIT2 NR3C1 NEB ADCY3 JUN | 1.64e-07 | 192 | 165 | 11 | 5509_DN |
| Drug | testosterone enanthate | TNPO1 NCOA3 PDE4A ANGPT1 WASHC4 ATRX PPP1R12A WWP2 ZNF510 RRBP1 ADCY3 PPP1R7 MBNL2 CEP57 ACBD3 HSPA4 GOLGA1 GOLGA4 | 2.11e-07 | 575 | 165 | 18 | ctd:C004648 |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; MCF7; HT_HG-U133A | ROCK2 CEP85 VPS39 GIT2 NR3C1 RRBP1 ADCY3 PPP1R7 PIGT DDX43 GOLGB1 | 2.35e-07 | 199 | 165 | 11 | 5349_DN |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.38e-06 | 191 | 165 | 10 | 5296_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | CNTRL LAMB1 GIT2 ADCY3 SGMS1 FAM120C ROBO1 PLCB3 ATP2A3 GOLGB1 | 1.83e-06 | 197 | 165 | 10 | 5564_DN |
| Drug | Clorgyline | 3.91e-06 | 168 | 165 | 9 | ctd:D003010 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 4.52e-06 | 171 | 165 | 9 | 7535_DN | |
| Drug | AC1NST48 | UBQLN1 VPS39 DCTN2 HS6ST2 WWP2 JUN AKAP4 AKAP9 RABEP1 GCC2 CTSD HSPA4 GOLGA1 GOLGA4 GOLGB1 CREB3 | 7.09e-06 | 594 | 165 | 16 | CID005315496 |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.95e-06 | 186 | 165 | 9 | 5000_DN | |
| Drug | wortmannin; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 1.02e-05 | 189 | 165 | 9 | 911_UP | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.25e-05 | 194 | 165 | 9 | 5303_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 1.42e-05 | 197 | 165 | 9 | 5843_UP | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 165 | 9 | 5545_DN | |
| Drug | Famotidine [76824-35-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.54e-05 | 199 | 165 | 9 | 6665_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.60e-05 | 200 | 165 | 9 | 2061_DN | |
| Drug | Antigens, Polyomavirus Transforming | CCDC14 NCOA3 MYH9 CEP85 CENPF KIAA0232 PPP1R12A CNTRL SMC4 LAMB1 TSC1 CEP192 S100A4 MBNL2 SCLT1 ZNF292 | 2.99e-05 | 668 | 165 | 16 | ctd:D000952 |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; HL60; HG-U133A | 3.06e-05 | 167 | 165 | 8 | 1398_UP | |
| Drug | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | FOXO3 IL12A ANGPT1 NR3C1 S100A4 JUN OSM CD36 TLR1 PLCB3 CDH1 HSPA4 | 3.89e-05 | 402 | 165 | 12 | ctd:C093973 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.22e-05 | 180 | 165 | 8 | 4541_DN | |
| Drug | 2,5-DNP | 5.22e-05 | 2 | 165 | 2 | CID000009492 | |
| Drug | Mono(2-methacryloyloxy)ethyl phthalate | 5.22e-05 | 2 | 165 | 2 | CID000119704 | |
| Drug | R 478 | 5.91e-05 | 11 | 165 | 3 | CID000084223 | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 6.33e-05 | 185 | 165 | 8 | 1673_DN | |
| Drug | chrysene | ROCK2 NCOA3 PDE4A VPS39 KIAA0232 UTP14A LAMB1 NEB RYR1 CEP63 JUN CLEC4F SGMS1 POMP SYNE2 NUFIP2 ROBO1 FDXACB1 | 6.46e-05 | 871 | 165 | 18 | ctd:C031180 |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 7.08e-05 | 188 | 165 | 8 | 5493_UP | |
| Drug | zaprinast | 7.74e-05 | 141 | 165 | 7 | CID000005722 | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; PC3; HT_HG-U133A | 7.91e-05 | 191 | 165 | 8 | 5085_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.21e-05 | 192 | 165 | 8 | 6435_DN | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 8.21e-05 | 192 | 165 | 8 | 4244_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 8.21e-05 | 192 | 165 | 8 | 7280_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 8.21e-05 | 192 | 165 | 8 | 2865_DN | |
| Drug | geldanamycin | ROCK2 ANGPT1 ATRX CCDC186 ZNF518A S100A4 MBNL2 RABEP1 KIRREL1 CDH1 HSPA4 | 8.72e-05 | 371 | 165 | 11 | ctd:C001277 |
| Drug | wartmannin | ROCK2 FOXO3 RAD52 IL12A MYH9 ANGPT1 PPP1R12A TSC1 JUN CD36 GSTCD CCAR1 CTSD CDH1 HSPA4 GOLGB1 CREB3 | 8.77e-05 | 811 | 165 | 17 | CID000005691 |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 8.82e-05 | 194 | 165 | 8 | 3366_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A | 8.82e-05 | 194 | 165 | 8 | 4758_DN | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.82e-05 | 194 | 165 | 8 | 5674_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 7254_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 3478_UP | |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; MCF7; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 6510_DN | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 5053_DN | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 6514_DN | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 2820_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 9.47e-05 | 196 | 165 | 8 | 987_DN | |
| Drug | Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 7455_DN | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 1301_DN | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 2856_DN | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 3767_DN | |
| Drug | Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 5437_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 7169_UP | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 3234_DN | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 3270_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; HL60; HG-U133A | 9.81e-05 | 197 | 165 | 8 | 1363_UP | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; HL60; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 6161_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 2845_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 3769_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 7171_DN | |
| Drug | 5155877; Down 200; 10uM; PC3; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 6544_DN | |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 5413_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 7034_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 7500_DN | |
| Drug | Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 6211_DN | |
| Drug | Ronidazole [7681-76-7]; Down 200; 20uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 3557_DN | |
| Drug | Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 5358_DN | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 5059_DN | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 6254_UP | |
| Drug | Suramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 7524_DN | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 3451_UP | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; HL60; HT_HG-U133A | 1.09e-04 | 200 | 165 | 8 | 1869_UP | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.09e-04 | 200 | 165 | 8 | 6150_DN | |
| Drug | CP-944629 [668990-94-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 165 | 8 | 7544_DN | |
| Drug | pyrazolanthrone | 1.26e-04 | 322 | 165 | 10 | ctd:C432165 | |
| Drug | 9-beta-D-arabinofuranosylguanine | ROCK2 DOCK4 PDE4A PDE4C VPS39 PPP1R12A RBM23 ADCY3 RABEP1 GCC2 RHOBTB2 GSTCD PLCB3 MME POLQ TUBD1 GOLGB1 | 1.40e-04 | 843 | 165 | 17 | CID000000765 |
| Drug | maltose tetrapalmitate | 1.56e-04 | 3 | 165 | 2 | CID003035236 | |
| Drug | arsenic | 1.81e-04 | 274 | 165 | 9 | CID005359596 | |
| Drug | DB04210 | 1.95e-04 | 16 | 165 | 3 | CID005287853 | |
| Disease | colon cancer (implicated_via_orthology) | 2.60e-05 | 11 | 162 | 3 | DOID:219 (implicated_via_orthology) | |
| Disease | mucoepidermoid carcinoma (is_implicated_in) | 3.00e-05 | 2 | 162 | 2 | DOID:4531 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | ARHGAP42 TNPO1 KIAA0232 FCHO2 RBM23 F8 SGMS1 GPR158 CD36 SYNE2 NUFIP2 VPS13A RP1 PIBF1 TUBD1 CEP57 CDH1 HEATR3 FDXACB1 | 1.59e-04 | 1347 | 162 | 19 | EFO_0005192 |
| Disease | Prostatic Neoplasms | NCOA3 RNF31 CENPF NR3C1 ATAD3A GSTCD ROBO1 MME CTSD CDH1 GOLGA4 ZNF292 | 1.62e-04 | 616 | 162 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | NCOA3 RNF31 CENPF NR3C1 ATAD3A GSTCD ROBO1 MME CTSD CDH1 GOLGA4 ZNF292 | 1.62e-04 | 616 | 162 | 12 | C0376358 |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.78e-04 | 4 | 162 | 2 | cv:CN293514 | |
| Disease | Malignant neoplasm of breast | NCOA3 MYH9 CENPF VPS39 SYNE1 UBR4 LAMA2 JUN AKAP9 SYNE2 ROBO1 MME CDH1 ZNF281 ATP2A3 GOLGB1 | 2.95e-04 | 1074 | 162 | 16 | C0006142 |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.96e-04 | 5 | 162 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.96e-04 | 5 | 162 | 2 | C0410190 | |
| Disease | mean corpuscular hemoglobin concentration | TNPO1 RAD52 ANGPT1 STK17A LRSAM1 FCHO2 NEB CD36 VPS13A PLCB3 PIBF1 CEP57 CDH1 LRIF1 HEATR3 GOLGB1 | 4.03e-04 | 1105 | 162 | 16 | EFO_0004528 |
| Disease | Emery-Dreifuss muscular dystrophy | 4.43e-04 | 6 | 162 | 2 | cv:C0410189 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 4.43e-04 | 6 | 162 | 2 | C1854678 | |
| Disease | Congenital muscular dystrophy (disorder) | 4.43e-04 | 6 | 162 | 2 | C0699743 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.43e-04 | 6 | 162 | 2 | C0410189 | |
| Disease | Carcinoma, Lobular | 4.43e-04 | 6 | 162 | 2 | C0206692 | |
| Disease | mean reticulocyte volume | TNPO1 MYH9 ANGPT1 STK17A SMCO1 ZNF510 NEB CD36 VPS13A TUBD1 HSPA4 HEATR3 GOLGB1 | 4.90e-04 | 799 | 162 | 13 | EFO_0010701 |
| Disease | 10-undecenoate 11:1n1 measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0021099 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 6.18e-04 | 7 | 162 | 2 | C0751337 | |
| Disease | lysosomal Pro-X carboxypeptidase measurement | 8.21e-04 | 8 | 162 | 2 | EFO_0801777 | |
| Disease | FEV/FEC ratio | ARHGAP42 FOXO3 MYH9 KIAA0232 UTP14A NR3C1 RRBP1 NEB ADCY3 SPTBN5 SGMS1 SYNE2 GSTCD DNAH5 ATP2A3 HSPA4 | 1.23e-03 | 1228 | 162 | 16 | EFO_0004713 |
| Disease | endometrial adenocarcinoma (is_marker_for) | 1.59e-03 | 11 | 162 | 2 | DOID:2870 (is_marker_for) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.91e-03 | 12 | 162 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Congenital muscular dystrophy | 1.91e-03 | 12 | 162 | 2 | cv:C0699743 | |
| Disease | Congenital myopathy (disorder) | 1.91e-03 | 12 | 162 | 2 | C0270960 | |
| Disease | precuneus cortex volume measurement | 2.61e-03 | 14 | 162 | 2 | EFO_0010326 | |
| Disease | Autistic Disorder | 3.28e-03 | 261 | 162 | 6 | C0004352 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.42e-03 | 16 | 162 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Neoplasm Invasiveness | 3.55e-03 | 184 | 162 | 5 | C0027626 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.86e-03 | 17 | 162 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 3.86e-03 | 17 | 162 | 2 | OBA_2045173 | |
| Disease | dermatomyositis (is_marker_for) | 3.86e-03 | 17 | 162 | 2 | DOID:10223 (is_marker_for) | |
| Disease | intelligence, self reported educational attainment | 4.01e-03 | 117 | 162 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | Chronic myeloproliferative disorder | 4.82e-03 | 19 | 162 | 2 | C1292778 | |
| Disease | Squamous cell carcinoma | 4.93e-03 | 124 | 162 | 4 | C0007137 | |
| Disease | energy expenditure measurement | 5.33e-03 | 20 | 162 | 2 | EFO_0008005 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLNNSTNQNKFIEMK | 1161 | Q9BXT4 | |
| FNLSKISNQRMNNFL | 216 | Q8N1L4 | |
| MQFEKDNLITKQNQL | 681 | Q99996 | |
| SQLQSQCEQMKQTNI | 621 | Q7Z3E2 | |
| NSKMEQSNLEKLELN | 1816 | Q7Z7A1 | |
| KLLTQVRNLQFMSEN | 511 | Q8TC20 | |
| RLEMTAAKNTNNNQS | 176 | Q5JQC9 | |
| SQLQENLKISENMNL | 1091 | Q8IX12 | |
| NLKISENMNLQFENQ | 1096 | Q8IX12 | |
| QFENQMNKTIRNLST | 1106 | Q8IX12 | |
| AKDALNLAQMQEQTL | 71 | Q9NVI7 | |
| VQMNRNLSNEELTKS | 396 | Q0JRZ9 | |
| SSEQNRNLMNKLVNN | 1256 | Q9HAR2 | |
| KNLQLLKDMQSIQNS | 476 | Q86XR8 | |
| KSLQNSNSEQDLEMT | 266 | A6NC57 | |
| NLNDTDLQIMNFINL | 2226 | Q86UQ4 | |
| MQKKLQTLQSENSNL | 461 | Q14161 | |
| TTNNSVLQKQQLELM | 241 | Q15389 | |
| GQLNNLTAENKMLNS | 696 | Q8IYA2 | |
| AQSENDLLNSNQMLK | 486 | Q9Y592 | |
| TQQMIANSLKDNTTL | 356 | Q13561 | |
| SLQSLNMSLQNQLEE | 526 | Q49A88 | |
| NMSLQNQLEESLKSQ | 531 | Q49A88 | |
| SNQLMNTLRNDLQLS | 246 | Q96JC9 | |
| NALNSVSENQSLLRM | 911 | Q93084 | |
| ANRRIANSNNMNKSE | 116 | Q14CW9 | |
| QQLQAMTDKFSNLRE | 476 | Q2M243 | |
| MNTNDVKALLDTQNL | 321 | O95803 | |
| SQAEKNRLAAMANNL | 241 | Q86U06 | |
| QKANDQFLESQRLLM | 281 | Q15276 | |
| DTLALNNQMVTQNRT | 356 | P43351 | |
| QQKQQLTAQLSLMAL | 401 | H3BPF8 | |
| ASQQKQQLTAQLSLM | 201 | Q08AF8 | |
| DVMLNQTNLQFNNNK | 116 | Q9UGN5 | |
| LQKENNNTIHLNTMF | 11 | Q8NG78 | |
| KNILTAQLQEMKNQS | 146 | Q92805 | |
| NNKLNLQNKQSLTMD | 746 | P34932 | |
| NTQLASMANLRAEKN | 431 | Q5T3J3 | |
| QMDQNKAISQILQES | 436 | Q6UWE0 | |
| NSTLKQLMREFNTQL | 1991 | Q13439 | |
| QLMREFNTQLAQKEQ | 1996 | Q13439 | |
| LNVMLQSNKSREQNL | 136 | Q5T848 | |
| STANMLREQVAQLKQ | 296 | P05412 | |
| TNENDQAKLMISNPQ | 401 | Q8NI77 | |
| LNTDIQGMNRSQEKQ | 1271 | Q92628 | |
| TNEMLLNFNNLSSAR | 41 | Q9BQD3 | |
| SNQFLINTNSELALM | 481 | P27815 | |
| SNQFLINTNSELALM | 436 | Q08493 | |
| EFLQQSLRNKSLQMN | 456 | Q9ULK4 | |
| NKMTLAQIQNNFSLE | 301 | P08473 | |
| RQKYLSLQQMQELSN | 116 | Q9H9S0 | |
| SMDDQLNQLFNLLQQ | 536 | P63132 | |
| MLQNEAKTLLAQANS | 1721 | P07942 | |
| QQKQQIMAALNSQTA | 241 | Q9H3P7 | |
| MNTASLSQQQDQKPI | 336 | P04150 | |
| NRLFAVNQKNMTALE | 1801 | P24043 | |
| NFMKNLFLLSTRQNV | 1241 | P00451 | |
| SQLMAEKLQLQEQLQ | 876 | P35579 | |
| LQTLMKVAAQNLIQN | 71 | Q9NX70 | |
| SQNLLRAVSNMLQKA | 41 | P29459 | |
| GLLNQQSLKRSANQM | 126 | Q6P2C8 | |
| FDNNSMSNNIALLKT | 121 | Q6PEW0 | |
| SMDDQLNQLFNLLQQ | 536 | P63135 | |
| SMDDQLNQLFNLLQQ | 536 | Q9BXR3 | |
| QLNQDKMNFSTLRNI | 56 | Q9Y244 | |
| QSHRKEFLMNTLNQS | 311 | O94913 | |
| FKLAMNILAQNASRN | 136 | Q01970 | |
| SMDDQLNQLFNLLQQ | 536 | Q9QC07 | |
| LSAMSNQQLEDLINQ | 2316 | P46100 | |
| QIQNLQNMDLDTIKE | 126 | Q7Z7G2 | |
| NEMSLQEKKDQNRNS | 141 | Q7Z4Q2 | |
| NRQVSQDLMQKLESL | 291 | Q7L8L6 | |
| TLQQQLDSQNMKKES | 246 | Q96LB3 | |
| LLLNVNNNMTTENLK | 1286 | Q9Y2F5 | |
| ASQQKQQLTAQLSLM | 201 | Q0D2H9 | |
| EQQLMRKNDQALQLT | 331 | Q86Z20 | |
| QQLKTLISQCQTRQM | 1481 | Q8N1I0 | |
| QQFQTLKMRISDQNI | 661 | Q6Y7W6 | |
| MLRDLQEKINQQENS | 536 | P49454 | |
| EINASLNQEKMNLIQ | 981 | P49454 | |
| SENQQLQKDLMNTKS | 511 | Q96MT8 | |
| NQFVQMILNSLINKS | 151 | P16671 | |
| DNLMQQKLVDQNIFS | 216 | P07339 | |
| SMNQLNSLLQKENLQ | 2056 | O75417 | |
| DNQLLMKNHIQTSFQ | 2036 | A8TX70 | |
| SSQNTLRLQFKAMQE | 6 | Q8IYE1 | |
| ATNLKMSDLRNQIQS | 216 | Q8IYE1 | |
| QQQKMDQLRSQVQSL | 586 | Q6P2H3 | |
| NLTTNQFLMQEVAKQ | 286 | Q9NX05 | |
| NLQKQLEEAMNTQLE | 151 | Q8IWJ2 | |
| LQQQLSKMEAQLFQL | 1461 | Q8IWJ2 | |
| TLKTNELFQTMQRAQ | 526 | A2RUB6 | |
| LAMKDTLTNINNQSF | 1021 | O60266 | |
| NLIQQKTAAAMLAQQ | 86 | Q5VZF2 | |
| NSKQNLNVSLSDEMN | 491 | Q8TEP8 | |
| MFQKLVNLQELALNQ | 141 | P40197 | |
| SNMVLSNSNQLLLKS | 346 | Q96J84 | |
| LMQNLTQSLSQKENR | 561 | Q96MM7 | |
| LNDLQMNNSVNLRSI | 356 | Q86TM3 | |
| RSMQQQETNLLANLT | 21 | Q9BZP3 | |
| DKALTQQQVASMQSQ | 596 | Q9BRP7 | |
| TAQNMELQNKVQLLE | 186 | O43889 | |
| ENNNKLTMLDIASNR | 271 | Q15435 | |
| QNEINNMSFLTADNK | 3461 | P21817 | |
| MSQIDLQEKNQELLN | 411 | Q68D86 | |
| MSSDRALRKQQQLNN | 416 | Q8NEC7 | |
| LNDLQMSNFVNLKNI | 376 | Q9NXZ2 | |
| NMQKDLENSNAKLQE | 1806 | Q02224 | |
| QLKKQFEAQNLSMQS | 2001 | Q02224 | |
| NLKLMDNQNKDQVTT | 666 | P12830 | |
| INFRDSNSASNMKQN | 991 | Q8TE73 | |
| LKANNVLEELNMSNN | 271 | Q6ZQY2 | |
| SILENEQRSNLMNNI | 221 | Q86X27 | |
| MNEQSQKTQNISSFD | 91 | Q96E29 | |
| NNKASMRQNLIDNAI | 1971 | P56715 | |
| NSLRQSPMQTIQENK | 441 | O43524 | |
| QLRQTVEATNSMNKN | 1886 | Q8NF91 | |
| TQFNNVVNKLRLMEQ | 3591 | Q8NF91 | |
| LMNKVQDTEISLQQQ | 2631 | Q8WXH0 | |
| NERLQTMVQNTKAEL | 1856 | Q8N4C6 | |
| RNLSMAVQKFSQSLQ | 51 | A6NI28 | |
| FNSQMAQQLSLELNL | 126 | Q9NVN3 | |
| RQKYLSLQQMQELSN | 116 | Q6NSW7 | |
| QMQLDDSTQLNSDLK | 1666 | Q9Y2K3 | |
| QMENNNLDELNKSKI | 336 | Q9NXP7 | |
| QQFLNQSRQALELKM | 1181 | Q9Y6Q9 | |
| NILNNEAFMNQEITK | 466 | Q9BYZ6 | |
| QKLMSNLDSNRDNEV | 56 | P26447 | |
| NETNTEMQRNKQDLP | 316 | Q562F6 | |
| ALTQMKESAEQNLQA | 91 | Q9UIF3 | |
| QNKSQQALLQSEKML | 451 | Q9NQW1 | |
| TSDNSRKQMVRNINN | 1526 | Q5VT25 | |
| QLQKQTDLMQDTSRL | 41 | P13725 | |
| LDTAMLPAQLQKQQN | 2711 | Q9NRC6 | |
| NDKQETFLNISQMNL | 266 | Q9UEE5 | |
| QMKSLQQLDISQNSV | 396 | Q15399 | |
| QQLESFQALRMQTLQ | 61 | Q8TBZ0 | |
| FQQQAQALSETMKQA | 166 | Q0P6D6 | |
| QTQMLDSNLQKASAE | 406 | Q8N1N0 | |
| NMNISNKIRNLSTTL | 96 | Q5QGZ9 | |
| QMSLSNKLEQNQLYG | 86 | Q8N8G6 | |
| FNLSKISNQRMNNFL | 216 | Q86W10 | |
| RLQKLLQDNNVMFNT | 941 | Q96EP0 | |
| FNQKVTLMLLDQNNR | 426 | Q12933 | |
| QNLEDQYSNSLKMNQ | 156 | Q9UJT1 | |
| VSQKLSNSESVQQQM | 831 | Q92574 | |
| NMQLTLNLQTENKGS | 116 | O00308 | |
| NNKVQLMVTDSELSN | 2256 | Q96RL7 | |
| QQQQMAELHSKLQSS | 911 | Q9P2E9 | |
| NLNIVQDKIMQQETS | 236 | Q7Z417 | |
| QAQLQAQKEELQSLM | 286 | Q96AQ6 | |
| LDTAMINNSRNLNIQ | 321 | Q969N2 | |
| SQIAQLQEENKQLMT | 121 | Q5EBL4 | |
| FDSIMKQQSQLSKLQ | 116 | Q15813 | |
| TNFSELQSQMQRQLL | 166 | Q9UMX0 | |
| SMDDQLNQLFNLLQQ | 536 | P10266 | |
| QTKNQMALDLEQLLN | 666 | Q8WXW3 | |
| SMDDQLNQLFNLLQQ | 536 | P63133 | |
| AQQSQLKVMDQQSFN | 2456 | Q9H5I5 | |
| LTQKLNNVNNQLFMT | 1686 | O60281 | |
| GKTNESQISNNINMQ | 421 | Q9Y2X9 | |
| SMDDQLNQLFNLLQQ | 536 | Q9UQG0 | |
| TQNDLKMQTQQVNTL | 806 | O75116 | |
| SQLQNDSKKAMQIQE | 781 | Q9NTJ3 | |
| ANQQVLKEASQMNLL | 351 | Q86VZ5 | |
| QAMQEQLSKNKELTQ | 321 | Q9BVJ6 | |
| NQLDNKQTNLMLPES | 1021 | Q9Y6N7 | |
| SMQLLEEANLQKSQA | 336 | Q96NL6 | |
| NMVKNQALQDSLLRA | 171 | Q147U7 | |
| NMLSEQQSTKLNISD | 1066 | Q6AHZ1 | |
| NRQLANMVNNLKEIS | 66 | P19474 | |
| VNLVQKTLAQAMLNN | 621 | Q92973 | |
| QQMQELSNILNLSYK | 66 | Q8N7R0 | |
| ELMQSLNQDSNSNFK | 626 | Q15643 | |
| DQNQSKMQLLQSLQE | 921 | Q15643 | |
| LQLLQRETMENSKNF | 61 | A0A0B4J280 | |
| ASQDEKLLQTMNLTQ | 1096 | Q2M389 | |
| TLFQEQQKMNISQAS | 31 | Q9Y2H8 | |
| QTLEMNLTNLVKRNS | 241 | Q9UJV3 | |
| QKEVQMNFLNQLTSV | 186 | Q5T4S7 | |
| QMKANDPSLQEVNLN | 191 | Q9NZR1 | |
| MATQIQQLLQDKQFE | 311 | Q96JC1 | |
| TLSQMNRDQLQKFVQ | 191 | Q9H7M6 | |
| QMNQTLQDKTNQIDL | 1096 | Q14789 | |
| LIESTANMDNNQSQK | 301 | O14974 | |
| SLEQVLAKNNALNMN | 3191 | P20929 |